OBO_ID (LABEL):	GO_0006915 (apoptotic process)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
BMJ_2012_Jan_30_344_e184	1/2012	S93-BMJ_2012_Jan_30_344_e184	['other infant clinical outcomes\nno Anaphylactic reactions were reported.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 34, 'anaphylactic')]
PMC1184067	7/2005	S79-PMC1184067	["caption (table-wrap): table 4\n\njapanese family physicians' self-reports of Preconception care in their clinical practice (n = 268)never/almost neversometimesoften/alwaysno responsen(%)n(%)n(%)n(%)timing of Intercourse to maximize chances of Conception222(82.8)20(7.5)9(3.6)17(6.3)Folic Acid supplementation217(81.0)24(9.0)11(4.1)16(6.0)exercise during Pregnancy198(73.9)32(11.9)20(7.5)18(6.7)testing for rubella Antibody180(67.2)55(20.5)21(7.8)12(4.5)increasing Calcium intake168(62.7)61(22.7)27(10.1)12(4.5)restricting Caffeine intake166(61.9)55(20.5)31(11.6)16(6.0)use of basal body temperature monitoring157(58.6)60(22.4)38(14.2)13(4.9)restricting Alcohol Intake107(39.9)74(27.6)72(26.9)15(5.6)testing for anemia56(20.9)112(41.8)94(35.1)6(2.2)smoking cessation37(13.8)63(23.5)162(60.4)6(2.2)\ntheir attitudes about providing Preconception care are depicted in table5."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 75, 'preconception'), ('GO_0006954', 'inflammatory response', 206, 'intercourse'), ('GO_0007631', 'feeding behavior', 241, 'conception222'), ('CHEBI_30751', 'formic acid', 280, 'Folic acid'), ('GO_0006915', 'apoptotic process', 352, 'pregnancy198'), ('GO_0044222', 'anammoxosome', 412, 'antibody180'), ('CHEBI_22313', 'alkaline earth metal atom', 462, 'calcium'), ('CHEBI_27732', 'caffeine', 520, 'caffeine'), ('CHEBI_30879', 'alcohol', 651, 'alcohol'), ('GO_0042432', 'indole biosynthetic process', 659, 'intake107'), ('GO_0007565', 'female pregnancy', 827, 'preconception')]
PMC1544352	6/2006	S110-PMC1544352	['sixty-five percent of women had english as their first language\n\ncaption (table-wrap): table 2\n\nbackground characteristics of participants(n = 588)characteristicno.%age (median, range)32 (18–46)marital status (n = 584)\u2003married422 72.3 \u2003living with partner118 20.2 \u2003has partner, not cohabiting17 2.9 \u2003single21 3.6 \u2003separated or divorced5 0.9 \u2003widowed1 0.2secondary schooling (n = 584)\u2003completed secondary school to final year (12)475 81.3 \u2003did not complete secondary school97 16.6 \u2003attended primary school only10 1.7 \u2003did not attend primary school2 0.3higher education (n = 560)\u2003degree or higher235 42.0 \u2003no degree325 58.0taxable income for the household for last year, aud (n = 516)*\u2003< $20,00082 15.9 \u2003$20,000–$30,00075 14.5 \u2003$30,000–$40,00066 12.8 \u2003$40,000–$50,00063 12.2 \u2003> $50,000230 44.6country of Birth (only top 7 listed) (n = 583)\u2003australia314 53.9 \u2003vietnam66 11.3 \u2003china31 5.3 \u2003new zealand18 3.1 \u2003india15 2.6 \u2003uk and eire13 2.2 \u2003turkey10 1.7if not Born in australia, years in australia (n = 256)\u2003mean (sd)10 (sd 9.2) \u2003median (range)8 (0–36)english first language (n = 581)\u2003yes378 65.1religion (n = 505)\u2003christian237 46.9 \u2003muslim55 10.9 \u2003buddhist49 9.7 \u2003hindu8 1.6 \u2003other4 0.8 \u2003none152 30.0pre-Pregnancy smoking (579)\u2003none436 75.3 \u20031–983 14.3 \u200310–1940 6.9 \u200320–2916 2.8 \u200330–394 0.7 \u2003>400 -Gestation at recruitment (n = 575)\u2003mean (sd)38.45 (sd 1.28) \u2003median (range)38 (29–42)first baby (n = 582)\u2003yes310 53.3previous Pregnancy losses (could tick more than one option)\u2003termination of Pregnancy134 22.8 \u2003Miscarriage (including ectopic Pregnancies)113 19.2 \u2003Stillbirth >20 weeks Gestation6 1.0 \u2003Neonatal Death1 0.2 \u2003none of these353 60model of Pregnancy care (n = 586)\u2003public hospital clinic (doctor or midwife)280 47.7 \u2003shared care (majority of care with local family doctor)171 29.2 \u2003team midwifery or midwives clinic93 15.9 \u2003family Birth centre41 7.0\n* australian average annual income for those is currently employed is $42,484 (australian bureau of statistics, feb 2006,); for those not currently employed, government pensions and allowances provide income support of up to approximately $10–12,000 per year\ntable3shows the breakdown of the proportion of women who took herbal Supplements; 36% of our sample took at least one Herbal Medicine Supplement.']	N/A	N/A	[('GO_0007567', 'parturition', 802, 'birth'), ('GO_0007567', 'parturition', 956, 'born'), ('GO_0007565', 'female pregnancy', 1201, 'pregnancy'), ('GO_0006266', 'DNA ligation', 1295, 'Gestation'), ('GO_0007565', 'female pregnancy', 1421, 'pregnancy'), ('GO_0006915', 'apoptotic process', 1487, 'pregnancy134'), ('GO_0046660', 'female sex differentiation', 1506, 'Miscarriage'), ('GO_0007565', 'female pregnancy', 1537, 'pregnancies'), ('GO_0001967', 'suckling behavior', 1559, 'Stillbirth'), ('GO_0007565', 'female pregnancy', 1580, 'gestation6'), ('GO_0007569', 'cell aging', 1596, 'Neonatal'), ('GO_0007586', 'digestion', 1605, 'death1'), ('GO_0007565', 'female pregnancy', 1645, 'pregnancy'), ('GO_0007567', 'parturition', 1836, 'Birth'), ('CHEBI_33341', 'titanium atom', 2183, 'supplements'), ('CHEBI_5775', 'hydralazine', 2232, 'herbal medicine'), ('CHEBI_16158', 'steroid sulfate', 2248, 'supplement')]
PMC1779612	12/2006	S34-PMC1779612	['in univariate analyses, Awareness of cmv increased with higher levels of education ( p -value for trend < .0001), older age ( p -value for trend = .02), and varied by study site, with awareness being highest in houston and birmingham and lowest in chicago (table 1).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 24, 'awareness')]
PMC2396486	6/2008	S16-PMC2396486	['briefly, Dvd-deficient neonates had larger Lateral Ventricles, increased Cellular Proliferation and reduced Apoptosis, altered Neurogenesis, reduced density of Neurotrophin Receptor (P75Ntr), and reduced levels of Nerve Growth Factor (Ngf) and Glial Cell Line-Derived Growth Factor (Gdnf) compared to controls[5]–[7].']	N/A	N/A	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 9, 'DVD'), ('UBERON_0002285', 'telencephalic ventricle', 43, 'lateral ventricles'), ('GO_0008283', 'cell proliferation', 73, 'cellular proliferation'), ('GO_0006915', 'apoptotic process', 108, 'apoptosis'), ('GO_0022008', 'neurogenesis', 127, 'neurogenesis'), ('PR_000001493', 'neuropeptide Y receptor type 2', 160, 'neurotrophin receptor'), ('PR_000001244', 'long-wave-sensitive opsin 1', 183, 'p75NTR'), ('PR_000011193', 'ephexin-1', 214, 'nerve growth factor'), ('UBERON_0001021', 'nerve', 214, 'nerve'), ('PR_000011159', 'nexilin', 235, 'NGF'), ('CL_0000125', 'glial cell', 244, 'glial cell'), ('PR_000007939', 'glial fibrillary acidic protein', 244, 'glial cell line-derived growth factor'), ('PR_000007939', 'glial fibrillary acidic protein', 283, 'GDNF')]
PMC2409299	5/2008	S127-PMC2409299	["edta Anticoagulated whole Blood samples were labelled within 6 hours of collection, Red Cells were Lysed according to the manufacturer's instructions, and the labelled cells stabilised and fixed."]	N/A	N/A	[('GO_0006915', 'apoptotic process', 5, 'anticoagulated'), ('UBERON_0000178', 'blood', 26, 'blood'), ('CL_0000232', 'erythrocyte', 84, 'red cells'), ('GO_0019835', 'cytolysis', 99, 'lysed')]
PMC2658734	4/2009	S57-PMC2658734	['Control of timing of developmental Processes [18], Haematopoietic Cell Differentiation [19], Apoptosis [20], Cell Proliferation and Organ Development [21].']	N/A	N/A	[('GO_0065007', 'biological regulation', 0, 'control'), ('GO_0007565', 'female pregnancy', 35, 'processes'), ('CL_0000988', 'hematopoietic cell', 51, 'haematopoietic cell'), ('GO_0060218', 'hematopoietic stem cell differentiation', 51, 'haematopoietic cell differentiation'), ('GO_0006915', 'apoptotic process', 93, 'apoptosis'), ('GO_0008283', 'cell proliferation', 109, 'cell proliferation'), ('GO_0048513', 'animal organ development', 132, 'organ development'), ('UBERON_0000062', 'organ', 132, 'organ')]
PMC2658734	4/2009	S62-PMC2658734	['caption (table-wrap): table\xa01\n\nvalidated and hypothetic Mirna targetsvalidated Mirna targets in type 2 diabetes and in the Endocrine systemmirnatargetfunctionreferencemir-375myotrophininhibition of Insulin secretion[69]mir-9onecut2 transcription factorinhibition of Glucose-stimulated Insulin Release[70]mir-192e-box repressorstgf-Beta-Induced Matrix Protein Collagen Col1A1 and -2[24]mir-143glut4, Hsl, Fatty Acid-Binding protein Ap2, Ppar-Μ2Adipocyte differentiation[49]hypothetic Mirna targets associated with type 2 diabetesmir-30 familyreceptor for advanced glycation end product, Immediate Early Response 3, Vimentin, Heat-Shock Protein-20Podocyte Apoptosis and Cytoskeletal structure[79,80]Mir-23Bhairy/Enhancer Of The Split Protein (Hes1)downstream target of activated Notch Signalling and Expressed in Nephron segments during development[81,84]mir-15, mir-16wnt and Β-Cateninnephron induction during Embryo Development[75,76]mir-7gy-boxnotch signalling[73,74]mir-4, mir-79Brd-boxmir-2, mir-11k-box\nBiogenesis Of Mirnas starts in the Nucleus (see figure3) where stretches of several kilobases long primary Mirnas (pri-Mirnas) are transcribed from the Genome, 3′- Polyadenylated [covalent Linkage Poly (a) tail of 3′ end of Mirna], 5′- capped [7-methyl guanylate (m7g) cap of 5′ end of Mirna].']	N/A	N/A	[('SO_0000276', 'miRNA', 56, 'miRNA'), ('SO_0000276', 'miRNA', 79, 'miRNA'), ('UBERON_0002049', 'vasculature', 123, 'endocrine'), ('PR_000045358', 'insulin family protein', 198, 'insulin'), ('CHEBI_17234', 'glucose', 266, 'glucose'), ('PR_000045358', 'insulin family protein', 285, 'insulin'), ('GO_0006260', 'DNA replication', 293, 'release'), ('PR_000004670', 'protein PTHB1', 330, '-beta-induced matrix protein collagen'), ('GO_0031012', 'extracellular matrix', 344, 'matrix'), ('PR_000003266', 'collagen type II alpha chain', 368, 'Col1a1'), ('PR_000010222', 'muscleblind-like protein 2', 380, '2'), ('PR_000008794', 'heat shock factor protein 5', 399, 'HSL'), ('CHEBI_35366', 'fatty acid', 404, 'fatty acid'), ('PR_000010000', 'lysozyme g-like protein 2', 414, '-binding'), ('PR_000004123', 'adenomatous polyposis coli protein 2', 431, 'aP2'), ('PR_000013031', 'periostin', 436, 'PPAR-μ2Adipocyte'), ('SO_0000276', 'miRNA', 483, 'miRNA'), ('PR_000000035', 'BMP receptor type-1A', 531, '-30'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 586, 'immediate early response 3'), ('PR_000017283', 'vitamin D3 receptor', 614, 'vimentin'), ('PR_000005163', 'CD2-associated protein', 624, 'heat-shock protein-20Podocyte'), ('GO_0006915', 'apoptotic process', 654, 'apoptosis'), ('GO_0005856', 'cytoskeleton', 668, 'cytoskeletal'), ('PR_000002103', 'sodium channel protein type 8 subunit alpha', 697, 'miR-23bHairy'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 710, 'enhancer of the split protein'), ('SO_0000165', 'enhancer', 710, 'enhancer'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 741, 'Hes1'), ('GO_0038189', 'neuropilin signaling pathway', 777, 'Notch signalling'), ('GO_0010467', 'gene expression', 798, 'expressed'), ('UBERON_0001285', 'nephron', 811, 'nephron'), ('PR_000002198', 'catenin beta-1', 875, 'β-cateninNephron'), ('GO_0009790', 'embryo development', 909, 'embryo development'), ('UBERON_0000922', 'embryo', 909, 'embryo'), ('PR_000011040', 'nuclear receptor coactivator 1', 979, '79Brd'), ('PR_000010222', 'muscleblind-like protein 2', 992, '2'), ('GO_0070277', 'iodide oxidation', 1007, 'Biogenesis of miRNAs'), ('SO_0000276', 'miRNA', 1021, 'miRNAs'), ('GO_0005634', 'nucleus', 1042, 'nucleus'), ('SO_0000276', 'miRNA', 1114, 'miRNAs'), ('SO_0000276', 'miRNA', 1126, 'miRNAs'), ('SO_0001026', 'genome', 1159, 'genome'), ('GO_0043651', 'linoleic acid metabolic process', 1171, 'polyadenylated'), ('SO_0000987', 'linear', 1196, 'linkage'), ('SO_0000610', 'polyA_sequence', 1204, 'poly'), ('SO_0000276', 'miRNA', 1231, 'miRNA'), ('SO_0000276', 'miRNA', 1293, 'miRNA')]
PMC2779500	11/2009	S15-PMC2779500	['intermediate concentrations of H2O2(and certain other Ros) result in the activation of Nuclear Factor Κ B (Nf- Κ B), a transcription factor that upregulates several Cellular Processes, including Cell Proliferation and Apoptosis [1,6,7].']	N/A	N/A	[('CHEBI_16240', 'hydrogen peroxide', 31, 'H2O2'), ('CHEBI_8756', 'RNA (poly(A))', 54, 'ROS'), ('GO_0005643', 'nuclear pore', 87, 'nuclear factor κ'), ('PR_000011193', 'ephexin-1', 87, 'nuclear factor κ B'), ('GO_0071159', 'NF-kappaB complex', 107, 'NF- κ'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 107, 'NF- κ B'), ('GO_0009987', 'cellular process', 165, 'cellular processes'), ('GO_0008283', 'cell proliferation', 195, 'cell proliferation'), ('GO_0006915', 'apoptotic process', 218, 'apoptosis')]
PMC2984417	10/2010	S103-PMC2984417	['caption (table-wrap): table 1\n\nsocio-demographic and Reproductive characteristics and infant outcomes in the study population, lima, peru, 2006-2008characteristicsplacental abruptionp-valuecases (n = 375)controls (n = 368)n%n%maternal age at Delivery (years)28.4 ± 6.7128.0 ± 6.30.38maternal age at delivery (years)\u2003< 203910.4308.20.30\u200320-2917446.419151.9\u200330-348622.97821.2\u2003≥ 357520.06718.2\u2003missing10.320.5parity1.32 ± 1.5011.46 ± 1.510.19\u2003016142.914639.70.63\u20031-214338.114539.4\u2003≥ 37118.97720.9≤ high school education24164.321658.70.29employed during Pregnancy18649.617647.80.66planned Pregnancy13335.511531.30.47no Prenatal care4110.9226.00.02no Prenatal Vitamin5715.24512.20.38smoking during Pregnancy82.161.60.48alcohol use during Pregnancy359.3308.20.67illicit Drug use during Pregnancy20.510.3- - -depressive symptoms3338.8102.7< 0.001pre-Pregnancy body mass index (kg/m2)23.7 ± 3.7123.4 ± 3.50.31pre-Pregnancy body mass index (kg/m2)\u2003< 19.83910.43810.30.38\u200319.8-26.022760.524566.6\u200326.1-29.04712.5369.8\u2003≥ 29.0277.2256.8\u2003missing359.3246.5chronic hypertension205.3102.70.07preeclampsia or eclampsia9826.1113.0< 0.001previous history of Placental abruption20.910.50.62infant Birth weight (grams)22438 ± 86013306 ± 502< 0.001low Birth weight infant (< 2500 grams)219652.3174.6< 0.001gestational age at delivery (weeks)235.3 ± 3.8138.7 ± 1.8< 0.001preterm delivery infant (< 37 weeks)220454.4205.4< 0.001c-section delivery35795.314439.1< 0.001stillbirth delivery5915.700.0- - -\n1mean ± sd (sd: standard deviation)\n2restricted to Live Birth only (314 cases and 368 controls)\n3phq-9 depression symptom score ≥ 10, consistent with moderate or severe depression\nthe lifetime prevalence of headaches or migraine was 40.0% for Placental abruption cases and 29.6% for controls (table2).']	N/A	N/A	[('GO_0000003', 'reproduction', 53, 'Reproductive'), ('GO_0007586', 'digestion', 242, 'Delivery'), ('GO_0030254', 'protein secretion by the type III secretion system', 550, 'Pregnancy18649'), ('GO_0006915', 'apoptotic process', 585, 'Pregnancy13335'), ('GO_0007565', 'female pregnancy', 615, 'Prenatal'), ('GO_0007565', 'female pregnancy', 646, 'Prenatal'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 655, 'Vitamin5715'), ('GO_0006412', 'translation', 693, 'Pregnancy82'), ('GO_0006412', 'translation', 733, 'Pregnancy359'), ('CHEBI_23888', 'drug', 764, 'Drug'), ('GO_0007608', 'sensory perception of smell', 780, 'Pregnancy20'), ('GO_0007565', 'female pregnancy', 843, 'pregnancy'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('UBERON_0001987', 'placenta', 1138, 'Placental'), ('GO_0007567', 'parturition', 1176, 'Birth'), ('GO_0007567', 'parturition', 1229, 'Birth'), ('GO_0008610', 'lipid biosynthetic process', 1528, 'live birth'), ('PR_000000035', 'BMP receptor type-1A', 1577, '-9'), ('UBERON_0001987', 'placenta', 1720, 'placental')]
PMC2991548	10/2010	S64-PMC2991548	['1\n\nenrolment and measurements until the age of 4\xa0years\n\ncaption (table-wrap): table\xa05\n\ncharacteristics of mothers and their partnersmotherspartners(n\xa0=\xa09,778)(n\xa0=\xa06,347)Gestational age at enrolment (%)\xa0early Pregnancy69–\xa0mid-Pregnancy19–\xa0late Pregnancy3–\xa0birth9–Pregnancy number in study (%)\xa01st Pregnancy94–\xa02nd Pregnancy6–\xa03rd Pregnancy0.1–age at enrolment (years)a29.9 (5.4)32.7 (5.7)parity (%)\xa0055–\xa0130–\xa0≥215–ethnicity (%)\xa0dutch, other-european5968\xa0surinamese97\xa0moroccan64\xa0turkish97\xa0dutch antilles33\xa0cape verdian42\xa0others109highest completed education (%)\xa0primary school118\xa0intermediate4641\xa0higher4351\nvalues are percentages.a\xa0mean (standard deviation)\n\nchildren at Birth and overall response\namong the live births, 51% were male and 49% female.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 169, 'Gestational'), ('GO_0007608', 'sensory perception of smell', 208, 'pregnancy69'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy19'), ('GO_0007565', 'female pregnancy', 243, 'pregnancy3'), ('GO_0007565', 'female pregnancy', 262, 'Pregnancy'), ('GO_0006915', 'apoptotic process', 296, 'pregnancy94'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy6'), ('GO_0007565', 'female pregnancy', 329, 'pregnancy0'), ('GO_0007567', 'parturition', 670, 'birth')]
PMC3001618	1/2011	S88-PMC3001618	['one consequence of this would be a decrease in Cell Proliferation and/or Apoptosis in Steatotic Hepatocytes (kmiec 2001).']	N/A	N/A	[('GO_0008283', 'cell proliferation', 47, 'cell proliferation'), ('GO_0006915', 'apoptotic process', 73, 'apoptosis'), ('CL_0000034', 'stem cell', 86, 'steatotic hepatocytes')]
PMC3029215	1/2011	S132-PMC3029215	['the biological systems (number of members in a Gene set) were: adhesion (146), Angiogenesis (131), Apoptosis (79), Coagulation (152), Hypoxia Response (109), inflammation (117), Redox Signaling (83), shear stress response (156), and Vasoregulation (106).']	N/A	N/A	[('SO_0000704', 'gene', 47, 'gene'), ('GO_0001525', 'angiogenesis', 79, 'angiogenesis'), ('GO_0006915', 'apoptotic process', 99, 'apoptosis'), ('GO_0050817', 'coagulation', 115, 'coagulation'), ('GO_0006972', 'hyperosmotic response', 134, 'hypoxia response'), ('GO_0016056', 'rhodopsin mediated signaling pathway', 178, 'redox signaling'), ('GO_0001574', 'ganglioside biosynthetic process', 233, 'vasoregulation')]
PMC3192420	7/2011	S90-PMC3192420	['detection of Apoptosis\nterminal transferase-mediated 2′-deoxyuridine, 5′-triphosphate nick end labeling (tunel) was determined using a fluorescence nikon eclipse 90i microscope using a similar protocol to that described above.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 13, 'apoptosis')]
PMC3202114	10/2011	S108-PMC3202114	['during late fetal and early Postnatal Life, the Beta-Cell mass is determined by the recruitment of undifferentiated precursors, as well as the Replication and Apoptosis rates of the Beta Cells.']	N/A	N/A	[('GO_0007567', 'parturition', 28, 'postnatal'), ('UBERON_0000104', 'life cycle', 38, 'life'), ('CL_0000349', 'extraembryonic cell', 48, 'beta-cell'), ('UBERON_0000922', 'embryo', 48, 'beta'), ('GO_0006260', 'DNA replication', 143, 'replication'), ('GO_0006915', 'apoptotic process', 159, 'apoptosis'), ('CL_0000365', 'animal zygote', 182, 'beta cells')]
PMC3202114	10/2011	S159-PMC3202114	['in an iupr Rat model with a decreased Beta-Cell mass and Beta-Cell Replication and an increased rate of Beta-Cell Apoptosis, Gene Expression for Igf-Ii but not Igf-I was found reduced in the fetal Pancreas [126].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 11, 'rat'), ('CL_0000349', 'extraembryonic cell', 38, 'beta-cell'), ('CL_0000349', 'extraembryonic cell', 57, 'beta-cell'), ('GO_0008219', 'cell death', 62, 'cell replication'), ('CL_0000349', 'extraembryonic cell', 104, 'beta-cell'), ('GO_0006915', 'apoptotic process', 109, 'cell apoptosis'), ('GO_0010467', 'gene expression', 125, 'gene expression'), ('SO_0000704', 'gene', 125, 'gene'), ('PR_000002046', 'interferon regulatory factor 4', 145, 'IGF-II'), ('PR_000008919', 'interferon alpha-6', 160, 'IGF-I'), ('UBERON_0001264', 'pancreas', 197, 'pancreas')]
PMC3250923	10/2011	S323-PMC3250923	['induced Abortions were the sole morbidity category for which women made their own healthcare decisions.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 8, 'abortions')]
PMC3257641	3/2010	S130-PMC3257641	['in experimental studies, Rats deprived of Vitamin D Prenatally had enlarged Lateral Ventricles, decreased Cortical thickness and heavier and longer Brains, and altered patterns of Apoptosis [70,71].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 25, 'rats'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0019230', 'proprioception', 52, 'prenatally'), ('UBERON_0002285', 'telencephalic ventricle', 76, 'lateral ventricles'), ('UBERON_0001851', 'cortex', 106, 'cortical'), ('UBERON_0000955', 'brain', 148, 'brains'), ('GO_0006915', 'apoptotic process', 180, 'apoptosis')]
PMC3338544	4/2012	S235-PMC3338544	['the sessions the 5c-srt were exclusively comprised of target trials in which accuracy, p(hit), omission rate, number of premature responses, number of Perseverative Responses and the latencies to make a correct response, an incorrect response and to collect reward were used to analyse the performance of Mice.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 151, 'perseverative responses'), ('NCBITaxon_10088', 'Mus <genus>', 305, 'mice')]
PMC3347007	4/2012	S123-PMC3347007	[')spring15,4311.1 (1.0, 1.1)1.0 (1.0, 1.1)summer15,9301.5 (1.4, 1.6)1.5 (1.4, 1.6)fall13,9121.3 (1.2, 1.3)1.2 (1.2, 1.3)\n* based on information from the Food frequency questionnaire and dnbc interview 1 and 2; ** adjusted for maternal age, pre-Pregnancy bmi, parity, civil status, socio-occupational status, physical activity level, season of filling out the ffq, smoking and alcohol use during Pregnancy, total energy intake, Planning Of Pregnancy; *** p -value for trend in the adjusted model.']	N/A	N/A	[('CHEBI_33290', 'food', 152, 'food'), ('GO_0007565', 'female pregnancy', 243, 'pregnancy'), ('GO_0007565', 'female pregnancy', 394, 'pregnancy'), ('GO_0006915', 'apoptotic process', 426, 'planning of pregnancy')]
PMC3404662	4/2012	S189-PMC3404662	['Permethrin, a Pyrethroid used in agriculture and in topical creams for lice and scabies induces oxidative stress and Apoptosis in the Nervous System of Zebrafish (shi et al.']	N/A	N/A	[('CHEBI_34911', 'permethrin', 0, 'Permethrin'), ('CHEBI_39397', 'tetramethrin', 14, 'pyrethroid'), ('GO_0006915', 'apoptotic process', 117, 'apoptosis'), ('UBERON_0001016', 'nervous system', 134, 'nervous system'), ('NCBITaxon_7955', 'Danio rerio', 152, 'zebrafish')]
PMC3407995	7/2012	S238-PMC3407995	['two hundred milligrams of dha, for the first 4 months of breastfeeding, results in higher infant bayley Psychomotor Development index at 30 months of age [118] and better performance on tests of sustained Attention.']	N/A	N/A	[('GO_0048339', 'paraxial mesoderm development', 104, 'Psychomotor Development'), ('GO_0006915', 'apoptotic process', 205, 'attention')]
PMC3420688	5/2012	S107-PMC3420688	['cytokines Ifn- Γ and Tnf- Α are also produced by Activated T Cells, which result in upregulation of the Fas Receptor causing Apoptosis Of target Cells [18].']	N/A	N/A	[('PR_000008920', 'interferon alpha-7', 10, 'IFN- γ'), ('PR_000000134', 'tumor necrosis factor alpha', 21, 'TNF- α'), ('CL_0002129', 'regular atrial cardiac myocyte', 49, 'activated T cells'), ('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 104, 'Fas receptor'), ('GO_0006915', 'apoptotic process', 125, 'apoptosis of ... cells')]
PMC3424155	8/2012	S200-PMC3424155	['nephrin does not affect Podocyte Apoptosis and Gene Expression patterns[36].']	N/A	N/A	[('CL_0000653', 'glomerular visceral epithelial cell', 24, 'podocyte'), ('GO_0006915', 'apoptotic process', 33, 'apoptosis'), ('GO_0010467', 'gene expression', 47, 'gene expression'), ('SO_0000704', 'gene', 47, 'gene')]
PMC3488410	10/2012	S163-PMC3488410	['administration of the nmda receptor antagonist Dizocilpine and Pcp in late fetal and early Postnatal Period Of Life in the Rat will increase Neuronal Death by Apoptosis [165].']	N/A	N/A	[('CHEBI_51622', '1H-diazirine', 47, 'dizocilpine'), ('PR_000012429', 'protein PCOTH', 63, 'PCP'), ('GO_0007567', 'parturition', 91, 'postnatal'), ('UBERON_0008264', 'echinopluteus larval stage', 101, 'period of life'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 123, 'rat'), ('CL_0000540', 'neuron', 141, 'neuronal'), ('GO_0019233', 'sensory perception of pain', 141, 'neuronal death'), ('GO_0006915', 'apoptotic process', 159, 'apoptosis')]
PMC3532199	11/2012	S31-PMC3532199	['in Humans, a finely choreographed cascade of Gene Expression, Cell Migration, Cell Transformation and Apoptosis between 14 and 60 days post Conception creates the soft and hard Tissues Of the Face from the originating Oropharyngeal Membrane.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('GO_0016477', 'cell migration', 62, 'cell migration'), ('GO_0033692', 'cellular polysaccharide biosynthetic process', 78, 'cell transformation'), ('GO_0006915', 'apoptotic process', 102, 'apoptosis'), ('GO_0007620', 'copulation', 140, 'conception'), ('UBERON_0004262', 'upper leg skin', 177, 'tissues of ... face'), ('UBERON_0009639', 'body of sphenoid', 218, 'oropharyngeal membrane')]
PMC3532199	11/2012	S467-PMC3532199	['the numbers of Spontaneous Abortions will be reported and the data safety monitoring board (dsmb) will determine whether these exceed the threshold for an adverse event.']	N/A	N/A	[('GO_0030474', 'spindle pole body duplication', 15, 'spontaneous'), ('GO_0006915', 'apoptotic process', 27, 'abortions')]
PMC3549390	1/2013	S19-PMC3549390	['her previous obstetrical history included two previous first Trimester Abortions and a full-term Pregnancy Delivered by cesarean section due to breech presentation.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 61, 'trimester'), ('GO_0006915', 'apoptotic process', 71, 'abortions'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('GO_0007567', 'parturition', 107, 'delivered')]
PMC3585827	1/2013	S224-PMC3585827	['caption (table-wrap): table 2\n\ntiming and type of measurement in start canada and indiameasuresantenatal visit (m)Birth (m, b)first year (m, b)12 month (m, b)24 month (m, b)36 month (m, f, b) \xa0 t1t2t3 \xa0 3 mth6 mth9 mth \xa0\xa0\xa0 demographics \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0ageic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0expected Delivery dateic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0medical and obstetric history\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0gravidaic\xa0c (m)\xa0\xa0\xa0\xa0\xa0\xa0current Gestational diabetesic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0current increased Blood pressureic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0increased Cholesterolic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0other major medical conditions checklistic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0family historyic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0medications usedic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0past Pregnancy history\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Live Birthsic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Still Birthsic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Abortions (therapeutic and spontaneous)ic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0past Gestational diabetesic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0pre-eclampsiaii/c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Multivitamin useii/c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 social determinants \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0self-reported ethnicity - for self, parents and grandparentsi\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0mother tongueic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0religious denominationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0years in canada\xa0c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0place immigrated fromic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0place of birthic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0annual household incomeic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0occupationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0marital statusic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0educationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0social supportic\xa0\xa0\xa0\xa0\xa0i/c (m)\xa0\xa0social status-mccarthur\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c\xa0\xa0acculturation\xa0\xa0\xa0\xa0\xa0\xa0\xa0c (m)\xa0\xa0Alcohol and tobacco use\xa0c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal depression\xa0i/c\xa0\xa0\xa0(m)\xa0i/c (m)\xa0\xa0intimate partner violence\xa0\xa0\xa0\xa0\xa0\xa0\xa0c(m)\xa0\xa0home environment and parenting\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c (m)\xa0\xa0infant temperament\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/ci/ci/csleep patterns\xa0\xa0\xa0\xa0cc\xa0i/c\xa0\xa0 diet \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0ffq\xa0i (mf)/c (m)\xa0i (b)\xa0\xa0\xa0i/c (m)\xa0i/c (m)24 hour recalli (m)ii(m)\xa0ii (m)ii/c (m)\xa0i/c (mother for baby)infant Feeding questions\xa0\xa0\xa0ii/ci/c\xa0i/c\xa0i/cphysical activityii/ci\xa0\xa0\xa0\xa0i/c (m)c (m)i/c (m) anthropometric measures \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Blood pressureii/cii/c (b)\xa0\xa0\xa0i/ci/ci/cheight/Lengthii/cii/c (b)i/c (b)\xa0ii/c\xa0i/cweightii/cii/c (b)i/c (b)i/c (b)1ii/ci/ci/Cwaist and Hip circumferenceii/ci\xa0\xa0\xa0\xa0i/ci/ci/cskin foldsii/cii/c (b)i\xa0ii/c (b)i/c (b)i/c (b, m)Head circumference\xa0\xa0\xa0i/c (b)i/ci/cii/c (b)\xa0i/c (b)Chest, mid upper Arm circumference\xa0\xa0\xa0i/c (b)iiii/c (b)\xa0i/c (b)fetal ultrasound\xa0i/c (m)i/c (m)i (b)\xa0\xa0\xa0i (b)i (b)i (b)dlw\xa0\xa0\xa0\xa0\xa0\xa0\xa0ii\xa0bia\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c (b)Blood specimens\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0hemoglobini (m)c (m)\xa0i/c (b)\xa0\xa0\xa0i/c (m)\xa0i/c (m, f)fasting Glucose\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c (b)i/c (b)i/c (b)75 g ogtt\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Insulin\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c (b)i/c (b)i/c (b)Lipids\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c\xa0i/calt\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Micronutrients (b12 Folate)\xa0i/ci\xa0\xa0\xa0\xa0\xa0\xa0\xa0dna/long term storage (Urine sample)\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Birth visit\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0type of Delivery\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Pregnancy weight gain\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0duration of labour\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0low Birth weight\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Premature Delivery\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Premature labour\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Blood loss\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Epidural\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Birth weight\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0apgar scores (1 min & 5 min)\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Vitamin K given\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0adverse outcomes\xa0\xa0\xa0i/c\xa0\xa0\xa0\xa0\xa0\xa0Placenta\xa0\xa0\xa0i/c\xa0\xa0\xa0\xa0\xa0\xa0Cord Blood\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0\nlegend: i india, c canada, b baby, m mother.']	N/A	N/A	[('GO_0007567', 'parturition', 114, 'Birth'), ('GO_0007586', 'digestion', 268, 'Delivery'), ('GO_0007565', 'female pregnancy', 359, 'gestational'), ('UBERON_0000178', 'blood', 407, 'blood'), ('CHEBI_62415', 'propanoyl-AMP', 441, 'cholesterolIC'), ('GO_0007565', 'female pregnancy', 567, 'Pregnancy'), ('GO_0019668', 'anaerobic catabolism of pairs of amino acids', 594, 'Live BirthsIC'), ('GO_0034209', 'sterol acetylation', 615, 'Still BirthsIC'), ('GO_0006915', 'apoptotic process', 637, 'Abortions'), ('GO_0007565', 'female pregnancy', 691, 'Gestational'), ('CHEBI_7025', 'mupirocin', 746, 'Multivitamin'), ('CHEBI_30879', 'alcohol', 1198, 'Alcohol'), ('GO_0007631', 'feeding behavior', 1538, 'Feeding'), ('UBERON_0000178', 'blood', 1653, 'Blood'), ('PR_000009651', 'laminin subunit alpha-2', 1698, 'LengthII'), ('UBERON_0007356', 'crop', 1774, 'CWaist'), ('UBERON_0006337', 'distal early tubule', 1785, 'Hip'), ('UBERON_0000033', 'head', 1869, 'Head'), ('UBERON_0012131', 'centrale', 1919, 'Chest'), ('UBERON_0001460', 'arm', 1936, 'arm'), ('UBERON_0000178', 'blood', 2067, 'Blood'), ('CHEBI_17234', 'glucose', 2149, 'Glucose'), ('PR_000045358', 'insulin family protein', 2221, 'Insulin'), ('CHEBI_18059', 'lipid', 2268, 'Lipids'), ('CHEBI_34850', 'milrinone lactate', 2319, 'Micronutrients'), ('CHEBI_81245', 'Vulpecholate', 2339, 'Folate'), ('UBERON_0001088', 'urine', 2381, 'urine'), ('GO_0007567', 'parturition', 2410, 'Birth'), ('GO_0007586', 'digestion', 2445, 'Delivery'), ('GO_0007565', 'female pregnancy', 2469, 'Pregnancy'), ('GO_0007567', 'parturition', 2544, 'Birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 2572, 'Premature'), ('GO_0007586', 'digestion', 2582, 'Delivery'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 2606, 'Premature'), ('UBERON_0000178', 'blood', 2638, 'Blood'), ('UBERON_2000660', 'epural', 2664, 'Epidural'), ('GO_0007567', 'parturition', 2688, 'Birth'), ('CHEBI_28384', 'vitamin K', 2760, 'Vitamin K'), ('UBERON_0001987', 'placenta', 2819, 'Placenta'), ('UBERON_0000948', 'heart', 2839, 'Cord'), ('UBERON_0000178', 'blood', 2844, 'Blood')]
PMC3586494	2/2013	S264-PMC3586494	['these Animals also had proteinuria, higher Lipid Peroxidation end products, and evidence of increased Renal Apoptosis and fibrosis [114,115].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 6, 'animals'), ('CHEBI_18059', 'lipid', 43, 'lipid'), ('GO_0032622', 'interleukin-19 production', 43, 'lipid peroxidation'), ('UBERON_0002113', 'kidney', 102, 'renal'), ('GO_0006915', 'apoptotic process', 108, 'apoptosis')]
PMC3710985	7/2013	S105-PMC3710985	['caption (table-wrap): table\xa03\n\ndescriptions of malformations reported in the assessed cohortcongenital malformation/abnormalityexposed to polytherapydaily dose (mg/day)timing of exposure\u2003Quetiapine25Throughout Pregnancychiari malformation\u2003Fluoxetine80Throughout Pregnancy\u2003Clonazepam0.5from week 18\u2003Zoplicone7.5throughout Pregnancy\u2003Quetiapine25Throughout Pregnancycongenital Heart defect\u2003citalopram60throughout Pregnancy\u2003Quetiapine400Throughout Pregnancyatrial Septal defect\u2003citalopram20from weeks 8–16\u2003Quetiapine12.5; 50up to week 36; from week 36small Bowel atresia\u2003citalopram60throughout Pregnancy\u2003Quetiapine400Throughout Pregnancyhypospadias\u2003atomextine40throughout Pregnancy\u2003Quetiapine25Up to week 7ureterocele with hydronephrosis of Left Kidney\u2003sertraline150 gradually decreased to 50throughout Pregnancy\u2003Olanzapine2.5throughout Pregnancyatrial Septal defect\u2003citalopram20throughout Pregnancyhealthy controls\u2003no Drugmacrocystic lymphatic malformation\u2003no drugventricular Septal defect\u2003no drugventricular Septal defect\n\nDelivery and neonatal outcomes\nthe exposed and comparison groups differed significantly in terms of the method of Delivery reported (p=0.042), with more scheduled c-sections occurring in the exposed group.']	N/A	N/A	[('CHEBI_82697', 'N-(ADP-D-ribosyl)diphthamide(1-) residue', 187, 'Quetiapine25Throughout'), ('GO_0012501', 'programmed cell death', 210, 'pregnancyChiari'), ('CHEBI_82170', 'Allidochlor', 239, 'Fluoxetine80Throughout'), ('GO_0007565', 'female pregnancy', 262, 'pregnancy'), ('CHEBI_3764', 'clotrimazole', 272, 'Clonazepam0'), ('CHEBI_81287', 'Paromomycin II', 298, 'Zoplicone7'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('CHEBI_82697', 'N-(ADP-D-ribosyl)diphthamide(1-) residue', 331, 'Quetiapine25Throughout'), ('GO_0030324', 'lung development', 354, 'pregnancyCongenital'), ('UBERON_0000948', 'heart', 374, 'heart'), ('GO_0007565', 'female pregnancy', 410, 'pregnancy'), ('CHEBI_82856', 'ethaboxam', 420, 'Quetiapine400Throughout'), ('GO_0007605', 'sensory perception of sound', 444, 'pregnancyAtrial'), ('UBERON_0003037', 'septum', 460, 'septal'), ('CHEBI_80336', 'Insulin-like 3', 502, 'Quetiapine12'), ('UBERON_0000160', 'intestine', 553, 'bowel'), ('GO_0007565', 'female pregnancy', 590, 'pregnancy'), ('CHEBI_82856', 'ethaboxam', 600, 'Quetiapine400Throughout'), ('GO_0006915', 'apoptotic process', 624, 'pregnancyHypospadias'), ('GO_0007565', 'female pregnancy', 668, 'pregnancy'), ('CHEBI_82033', 'propamocarb', 678, 'Quetiapine25Up'), ('UBERON_0004538', 'left kidney', 737, 'left kidney'), ('GO_0007565', 'female pregnancy', 799, 'pregnancy'), ('CHEBI_7765', 'Oligouronides', 809, 'Olanzapine2'), ('GO_0007605', 'sensory perception of sound', 833, 'pregnancyAtrial'), ('UBERON_0003037', 'septum', 849, 'septal'), ('GO_0006412', 'translation', 886, 'pregnancyHealthy'), ('CHEBI_64391', 'biogenic mineral', 915, 'drugMacrocystic'), ('UBERON_0003037', 'septum', 973, 'septal'), ('UBERON_0003037', 'septum', 1006, 'septal'), ('GO_0007586', 'digestion', 1021, 'Delivery'), ('GO_0007567', 'parturition', 1135, 'delivery')]
PMC3713405	7/2013	S93-PMC3713405	['Dvd deficiency also altered Gene Expression profiles Regulating mitosis and Apoptosis in the Brain (ko et al., 2004).']	N/A	N/A	[('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 0, 'DVD'), ('GO_0010467', 'gene expression', 28, 'gene expression'), ('SO_0000704', 'gene', 28, 'gene'), ('GO_0065007', 'biological regulation', 53, 'regulating'), ('GO_0006915', 'apoptotic process', 76, 'apoptosis'), ('UBERON_0000955', 'brain', 93, 'brain')]
PMC3739737	8/2013	S18-PMC3739737	['Prenatally Vitamin D-deficient neonates had increased Cell Proliferation and reduced Apoptosis[9].']	N/A	N/A	[('GO_0019230', 'proprioception', 0, 'Prenatally'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0008283', 'cell proliferation', 54, 'cell proliferation'), ('GO_0006915', 'apoptotic process', 85, 'apoptosis')]
PMC3740243	8/2013	S90-PMC3740243	['this change is characterized by Macrophage infiltration into Wat, Apoptosis and necrosis of Adipocytes, and reduced vascularity (shu et al.,2012).']	N/A	N/A	[('CL_0000235', 'macrophage', 32, 'macrophage'), ('UBERON_0006337', 'distal early tubule', 61, 'WAT'), ('GO_0006915', 'apoptotic process', 66, 'apoptosis'), ('CL_0000136', 'fat cell', 92, 'adipocytes')]
PMC3742769	8/2013	S126-PMC3742769	['N-3 Pufas attenuate Sevoflurane-induced Neuronal Apoptosis\nwe examined Cortical extracts with western blots to verify Activated Caspase-3 immunofluorescence represented Apoptosis, and to quantify the Apoptotic Response.']	N/A	N/A	[('PR_000011459', 'neurotrophin-3', 0, 'n-3'), ('CHEBI_37972', 'phosphorus-32 atom', 2, '3'), ('CHEBI_86926', 'S a S b S', 4, 'PUFAs'), ('CHEBI_6015', 'isoflurane', 20, 'sevoflurane'), ('CL_0000540', 'neuron', 40, 'neuronal'), ('GO_0006915', 'apoptotic process', 49, 'apoptosis'), ('UBERON_0001851', 'cortex', 71, 'cortical'), ('PR_000004139', 'adipocyte plasma membrane-associated protein', 118, 'activated caspase-3'), ('GO_0006915', 'apoptotic process', 169, 'apoptosis'), ('GO_0006915', 'apoptotic process', 200, 'apoptotic response')]
PMC3763666	7/2012	S45-PMC3763666	['stimulation of Tlrs by various pamps induces the Differentiation Of T Cells, with Th1 cells that mediates Cellular Responses and inflammatory reactions and Th2 Cells which mediates humoral responses, Antiparasitic Defense and allergic reactions [20].']	N/A	N/A	[('GO_0042462', 'eye photoreceptor cell development', 15, 'TLRs'), ('GO_0030154', 'cell differentiation', 49, 'differentiation of T cells'), ('CL_0000084', 'T cell', 68, 'T cells'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 82, 'Th1'), ('GO_0006915', 'apoptotic process', 106, 'cellular responses'), ('CL_0000546', 'T-helper 2 cell', 156, 'Th2 cells'), ('GO_0010142', 'farnesyl diphosphate biosynthetic process, mevalonate pathway', 200, 'antiparasitic defense')]
PMC3820434	12/2012	S70-PMC3820434	['the Macrophage-Derived Apoptosis Inhibitor Of Macrophage (Aim) protein is increased in Blood and is incorporated into Adipocytes, thereby inducing Lipolysis in at.']	N/A	N/A	[('CL_0000235', 'macrophage', 4, 'macrophage'), ('PR_000010134', 'mitogen-activated protein kinase kinase kinase 15', 4, 'macrophage-derived apoptosis inhibitor of macrophage'), ('GO_0006915', 'apoptotic process', 23, 'apoptosis'), ('CHEBI_35222', 'inhibitor', 33, 'inhibitor'), ('CL_0000235', 'macrophage', 46, 'macrophage'), ('PR_000003890', 'A-kinase anchor protein 3', 58, 'AIM'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CL_0000136', 'fat cell', 118, 'adipocytes'), ('GO_0016042', 'lipid catabolic process', 147, 'lipolysis')]
PMC3821254	4/2013	S62-PMC3821254	['it also increases the rate of Apoptosis.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 30, 'apoptosis')]
PMC3857567	12/2013	S4-PMC3857567	['hfd-exposed Prostate Tissues do not increase in size, but instead concomitantly up-regulate Apoptosis.']	N/A	N/A	[('UBERON_0002367', 'prostate gland', 12, 'prostate'), ('UBERON_0000479', 'tissue', 21, 'tissues'), ('GO_0006915', 'apoptotic process', 92, 'apoptosis')]
PMC3857567	12/2013	S80-PMC3857567	['at 16 weeks, Apoptosis was slightly more frequent in Prostate Acini from hfd-exposed Mice than in those from Chow-exposed Mice (fig.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 13, 'apoptosis'), ('UBERON_0008772', 'proximal epiphysis of tibia', 53, 'prostate acini'), ('NCBITaxon_10088', 'Mus <genus>', 85, 'mice'), ('CHEBI_33290', 'food', 109, 'chow'), ('NCBITaxon_10088', 'Mus <genus>', 122, 'mice')]
PMC3857567	12/2013	S82-PMC3857567	['at 26 weeks, no significant difference in Apoptosis was observed in Prostates from hfd- and Chow-exposed offspring (fig.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 42, 'apoptosis'), ('UBERON_0002496', 'stapes base', 68, 'prostates'), ('CHEBI_33290', 'food', 92, 'chow')]
PMC4045304	2/2014	S222-PMC4045304	['in a randomized controlled trial in Humans, 800 iu of Vitamin D increased the levels of Bax, which helps to stop mutations by promoting Apoptosis [98].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 36, 'humans'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000002193', 'apoptosis regulator BAX', 88, 'Bax'), ('GO_0006915', 'apoptotic process', 136, 'apoptosis')]
PMC4054662	7/2014	S18-PMC4054662	['this results in increased Apoptosis and necrosis of the Syncytiotrophoblast Layer lining the Intervillous space(10).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 26, 'apoptosis'), ('UBERON_0004021', 'spongiotrophoblast layer', 56, 'syncytiotrophoblast layer'), ('GO_0005911', 'cell-cell junction', 93, 'intervillous'), ('UBERON_0010746', 'iliac blade', 93, 'intervillous')]
PMC4062859	3/2014	S113-PMC4062859	['among all 23 Abortions in urban area, in 18 cases it occurred spontaneously and in remaining 5 cases by self-medication to abort the child due to medical and/or social reasons, while among rural participants, out of 13 Abortions, spontaneous Abortion occurred in 7 cases.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 13, 'abortions'), ('GO_0006915', 'apoptotic process', 219, 'abortions'), ('GO_0007569', 'cell aging', 242, 'abortion')]
PMC4065350	12/2013	S145-PMC4065350	['with the increase in afterload secondary to Ductal constriction, the fetal Heart initially shows proliferative Growing and, at later stages, hyperplasia is substituted to Apoptosis and a hypertrophic response (van den hoff et al.,2004).']	N/A	N/A	[('UBERON_0001505', 'coracobrachialis muscle', 44, 'ductal'), ('UBERON_0000948', 'heart', 75, 'heart'), ('GO_0040007', 'growth', 111, 'growing'), ('GO_0006915', 'apoptotic process', 171, 'apoptosis')]
PMC4071151	6/2014	S50-PMC4071151	['moreover, she refused Nutritional care and supplements prescribed after bariatric surgery (bs) until she had two spontaneous Abortions 16\xa0years post bs.']	N/A	N/A	[('CHEBI_7495', 'nefazodone hydrochloride', 22, 'nutritional'), ('GO_0006915', 'apoptotic process', 125, 'abortions')]
PMC4143239	8/2014	S139-PMC4143239	['more Leukocytes of malnourished children were found to have markers of Apoptosis (Cd95)[92], and signs of dna damage[117]–[118].']	N/A	N/A	[('CL_0000738', 'leukocyte', 5, 'leukocytes'), ('GO_0006915', 'apoptotic process', 71, 'apoptosis'), ('PR_000001309', 'CD70 molecule', 82, 'CD95')]
PMC4143239	8/2014	S303-PMC4143239	['Lymphocytes of malnourished children are less responsive to stimulation with Pha, fewer are activated and more cells have markers of Apoptosis.']	N/A	N/A	[('CL_0000849', 'crypt olfactory receptor neuron', 0, 'Lymphocytes'), ('CHEBI_34926', 'Pitrazepin', 77, 'PHA'), ('GO_0006915', 'apoptotic process', 133, 'apoptosis')]
PMC4155824	8/2014	S107-PMC4155824	['the supernatant of lgg was shown to prevent Apoptosis in Iecs [49] and induce heat shock proteins [50].']	N/A	N/A	[('GO_0006915', 'apoptotic process', 44, 'apoptosis'), ('CL_0002062', 'type I pneumocyte', 57, 'IECs')]
PMC4155824	8/2014	S110-PMC4155824	['each of the purified proteins was shown to activate the Akt signaling peptide, inhibit cytokine-induced Iec Apoptosis and reduce tumor necrosis factor (tnf)- induced Epithelial damage.']	N/A	N/A	[('GO_0000374', 'Group III intron splicing', 56, 'Akt'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 56, 'Akt'), ('CL_0002284', 'type X enteroendocrine cell', 104, 'IEC'), ('GO_0006915', 'apoptotic process', 108, 'apoptosis'), ('UBERON_0000483', 'epithelium', 166, 'epithelial')]
PMC4161853	8/2014	S137-PMC4161853	['additionally, salmonella -specific Antibodies facilitate specific T Cell Responses via augmentation of bacterial uptake and induction of Apoptosis in Macrophages [97].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibodies'), ('CL_0000084', 'T cell', 66, 'T cell'), ('GO_0001783', 'B cell apoptotic process', 66, 'T cell responses'), ('GO_0006915', 'apoptotic process', 137, 'apoptosis'), ('CL_0000235', 'macrophage', 150, 'macrophages')]
PMC4193257	7/1992	S189-PMC4193257	['the former are characterized, for example, by low maternal weight for height, presence of selected diseases such as diabetes or chronic hypertension, and a poor obstetric history (e.g., history of multiple spontaneous Abortions).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 218, 'abortions')]
PMC4208652	6/2014	S86-PMC4208652	['yes/no relevance for specific signaling pathways (smad; C‐Myc; P53; Er Α ) or processes (development, Cell Growth; Apoptosis) was verified by wet‐lab approaches (www.ncbi.nlm.nih.gov/sites/entrez; and manuscript in prep.).']	N/A	N/A	[('PR_000005009', 'calpain-1 catalytic subunit', 56, 'c‐Myc'), ('PR_000003035', 'cellular tumor antigen p53', 63, 'p53'), ('PR_000007120', 'ephrin type-A receptor 1', 68, 'ER α'), ('GO_0016049', 'cell growth', 102, 'cell growth'), ('GO_0006915', 'apoptotic process', 115, 'apoptosis')]
PMC4208652	6/2014	S217-PMC4208652	['the hh pathway and Regulatory clusters for Programmed Cell Death/Apoptosis were also identified as key Control pathways, that are shared between Human height and cancer.']	N/A	N/A	[('GO_0065007', 'biological regulation', 19, 'regulatory'), ('GO_0012501', 'programmed cell death', 43, 'programmed cell death'), ('GO_0006915', 'apoptotic process', 65, 'apoptosis'), ('GO_0065007', 'biological regulation', 103, 'control'), ('NCBITaxon_9606', 'Homo sapiens', 145, 'human')]
PMC4208652	6/2014	S230-PMC4208652	['equally C‐Myc dependent is the Estrogen‐induced suppression of Apoptosis caused by growth factor deprivation (rodrik et al.2005).']	N/A	N/A	[('PR_000005009', 'calpain-1 catalytic subunit', 8, 'c‐Myc'), ('CHEBI_50114', 'estrogen', 31, 'estrogen'), ('GO_0006915', 'apoptotic process', 63, 'apoptosis')]
PMC4208652	6/2014	S236-PMC4208652	['among its functions, P53 Regulates the Expression of target Genes that Modulate Chromatin structure and function (cimoli et al.2004; vousden and lane2007), cell growth, Aging and Apoptosis (ambrogi et al.2006; biganzoli et al.2011).']	N/A	N/A	[('PR_000003035', 'cellular tumor antigen p53', 21, 'p53'), ('GO_0065007', 'biological regulation', 25, 'regulates'), ('GO_0010467', 'gene expression', 39, 'expression'), ('SO_0000704', 'gene', 60, 'genes'), ('GO_0065007', 'biological regulation', 71, 'modulate'), ('GO_0000785', 'chromatin', 80, 'chromatin'), ('GO_0007568', 'aging', 169, 'aging'), ('GO_0006915', 'apoptotic process', 179, 'apoptosis')]
PMC4208652	6/2014	S242-PMC4208652	['female P53 ‐null Mice can present Neural Tube‐Closure defects, due to a failure to induce Apoptosis Of Progenitor Cells.']	N/A	N/A	[('PR_000003035', 'cellular tumor antigen p53', 7, 'p53'), ('NCBITaxon_10088', 'Mus <genus>', 17, 'mice'), ('UBERON_0001049', 'neural tube', 34, 'neural tube'), ('GO_0060606', 'tube closure', 41, 'tube‐closure'), ('GO_0006915', 'apoptotic process', 90, 'apoptosis of ... cells'), ('CL_0000826', 'pro-B cell', 103, 'progenitor cells')]
PMC4213680	12/2014	S21-PMC4213680	['uncontrolled follicle Apoptosis would reduce the number of available follicles (sun et al., 2012).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 22, 'apoptosis')]
PMC4213680	12/2014	S22-PMC4213680	['the ratio of pro-apoptotic factor Bcl-2 Associated x Protein (Bax) and anti-apoptotic factor B Cell Lymphoma/Leukemia-2 (Bcl-2) serves as a good marker for Ovarian Follicle Apoptosis (rucker et al., 2000).']	N/A	N/A	[('PR_000027209', 'caveolin-1 isoform 1', 34, 'bcl-2 associated'), ('PR_000004253', 'Rho guanine nucleotide exchange factor 18', 53, 'protein'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 62, 'BAX'), ('CL_0000236', 'B cell', 93, 'B cell'), ('PR_000004699', 'B-cell lymphoma 3 protein', 93, 'B cell lymphoma/leukemia-2'), ('PR_000002304', 'apoptosis regulator BAX isoform 6', 121, 'Bcl-2'), ('UBERON_0001305', 'ovarian follicle', 156, 'ovarian follicle'), ('GO_0006915', 'apoptotic process', 173, 'apoptosis')]
PMC4213680	12/2014	S131-PMC4213680	['in Mammals, follicle Apoptosis or follicular atresia begins from early Fetal Period with most follicles lost at Birth (ding et al., 2010).']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 3, 'mammals'), ('GO_0006915', 'apoptotic process', 21, 'apoptosis'), ('UBERON_0002375', 'cricoid cartilage', 71, 'fetal period'), ('GO_0007567', 'parturition', 112, 'birth')]
PMC4213680	12/2014	S133-PMC4213680	['the ratio of proapoptotic factor Bax and antiapoptotic factor Bcl-2 is an evaluation index for the level of Apoptosis (rucker et al., 2000;sun et al., 2012).']	N/A	N/A	[('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 33, 'BAX'), ('PR_000002304', 'apoptosis regulator BAX isoform 6', 62, 'Bcl-2'), ('GO_0006915', 'apoptotic process', 108, 'apoptosis')]
PMC4216381	10/2014	S136-PMC4216381	['a large number of Pregnancy losses are induced in our study population; 71% of the Abortions treated in timis county (i.e., bega hospital) were elective during 2008 [56].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 18, 'pregnancy'), ('GO_0006915', 'apoptotic process', 83, 'abortions')]
PMC4258799	11/2014	S29-PMC4258799	['oxidative stress develops upon an imbalance between systemic Production Of Ros and the ability to either readily Detoxify ros (antioxidant defenses) or repair the ensuing damage resulting from Lipid Peroxidation, dna damage and Apoptosis [12].']	N/A	N/A	[('GO_0006412', 'translation', 61, 'production of ROS'), ('GO_0098754', 'detoxification', 113, 'detoxify'), ('CHEBI_18059', 'lipid', 193, 'lipid'), ('GO_0032622', 'interleukin-19 production', 193, 'lipid peroxidation'), ('GO_0006915', 'apoptotic process', 228, 'apoptosis')]
PMC4258799	11/2014	S86-PMC4258799	['Mouse Embryo exposed to blue light had reduced Blastocyst Formation rates, higher Blastomeric Apoptosis rates and higher Ros Production in Morula [45].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mouse'), ('UBERON_0000922', 'embryo', 6, 'embryo'), ('GO_0001825', 'blastocyst formation', 47, 'blastocyst formation'), ('UBERON_0000358', 'blastocyst', 47, 'blastocyst'), ('CL_0000354', 'blastemal cell', 82, 'blastomeric'), ('GO_0001755', 'neural crest cell migration', 82, 'blastomeric'), ('GO_0006915', 'apoptotic process', 94, 'apoptosis'), ('CHEBI_8756', 'RNA (poly(A))', 121, 'ROS'), ('GO_0071605', 'monocyte chemotactic protein-1 production', 121, 'ROS production'), ('UBERON_0000085', 'morula', 139, 'morula')]
PMC4258799	11/2014	S130-PMC4258799	['decreased level of Embryo Apoptosis l-carnitine experimentalembryo0.3\xa0mg/ml or 0.6\xa0mg/ml\xa0L-Carnitineembryo culture medium without supplementation1.']	N/A	N/A	[('UBERON_0000922', 'embryo', 19, 'embryo'), ('GO_0006915', 'apoptotic process', 26, 'apoptosis'), ('CHEBI_64740', 'L-tryptophaniumyl group', 89, 'L-CarnitineEmbryo')]
PMC4280220	12/2014	S141-PMC4280220	['the Tnfrsf1A is a Gene member of the tnfr superfamily that activates the transcription factor Nf-Kb, mediates Apoptosis, and functions as regulators of inflammation.']	N/A	N/A	[('PR_000001958', 'tumor necrosis factor receptor superfamily member 1A', 4, 'TNFRSF1A'), ('SO_0000704', 'gene', 18, 'gene'), ('GO_0005883', 'neurofilament', 94, 'NF'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 94, 'NF-KB'), ('GO_0006915', 'apoptotic process', 110, 'apoptosis')]
PMC4287506	10/2014	S43-PMC4287506	['enrolled women were visited weekly by trained female workers to ascertain Pregnancy outcomes (Live Births, stillbirths, induced Abortions, or Miscarriages).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0008610', 'lipid biosynthetic process', 94, 'live births'), ('GO_0006915', 'apoptotic process', 128, 'abortions'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 142, 'miscarriages')]
PMC4287506	10/2014	S53-PMC4287506	['caption (table-wrap): table 1\n\noperational definitions of obstetric complication and near misses by type of Pregnancy outcomecategoryobstetric complicationnear miss Live Births or stillbirths - complications during Deliverypostpartum hemorrhage report of profuse bleeding or retained Placentareport of nearly dying\u2009+\u2009profuse bleedingsensitivity: 63-84%, specificity: 89-97% eclampsia convulsions (excluding epilepsy) and no high feverreport of nearly dying\u2009+\u2009convulsions (excluding epilepsy) and no high feversensitivity: 73-99%, specificity: 86-99% sepsis high fever\u2009+\u2009foul-smelling vaginal discharge or high fever\u2009+\u2009Lower Abdominal painreport of nearly dying\u2009+\u2009high feversensitivity: 69-74%, specificity: 95-98% obstructed labor (report of baby stuck\u2009+\u2009use of Saline drip with injection) or (report of baby stuck\u2009+\u2009injection only) or labor pains >24\xa0hoursreport of nearly dying\u2009+\u2009(report of baby stuck\u2009+\u2009use of Saline drip with injection) or (report of baby stuck\u2009+\u2009injection only) or Labor pains >24\xa0hourssensitivity: 56-70%, specificity: 99-100% induced Abortions or Miscarriagescategoryobstetric complicationnear misshemorrhage report of Vaginal bleeding (other than spotting) heavier than a normal period in 72\xa0hours following Pregnancy outcomereport of nearly dying\u2009+\u2009profuse bleeding sepsis high fever\u2009+\u2009foul-smelling vaginal discharge or high fever\u2009+\u2009lower Abdominal pain in 7\xa0days after Pregnancy outcomereport of nearly dying\u2009+\u2009high fever\ncaption: these definitions are based on who’s integrated management of Pregnancy and Childbirth guidelines [51].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('GO_0007618', 'mating', 165, 'Live'), ('GO_0007567', 'parturition', 170, 'Births'), ('GO_0006952', 'defense response', 215, 'deliveryPostpartum'), ('UBERON_0034878', 'prechordal mesoderm', 284, 'placentaReport'), ('UBERON_0002200', 'vasculature of head', 618, 'lower abdominal'), ('CHEBI_24866', 'salt', 762, 'saline'), ('CHEBI_24866', 'salt', 913, 'saline'), ('GO_0007612', 'learning', 987, 'labor'), ('GO_0006915', 'apoptotic process', 1058, 'abortions'), ('GO_0007475', 'apposition of dorsal and ventral imaginal disc-derived wing surfaces', 1071, 'miscarriagesCategoryObstetric'), ('UBERON_0001987', 'placenta', 1143, 'vaginal'), ('GO_0007565', 'female pregnancy', 1233, 'pregnancy'), ('UBERON_0000916', 'abdomen', 1366, 'abdominal'), ('GO_0007565', 'female pregnancy', 1397, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1521, 'Pregnancy'), ('GO_0007567', 'parturition', 1535, 'Childbirth')]
PMC4287506	10/2014	S58-PMC4287506	['for women with induced Abortions or Miscarriages, those who reported Vaginal bleeding (other than Blood spotting) heavier than a normal period in the three days after a Pregnancy outcome were classified with hemorrhage (table\xa01).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 23, 'abortions'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 36, 'miscarriages'), ('UBERON_0001987', 'placenta', 69, 'vaginal'), ('UBERON_0000178', 'blood', 98, 'blood'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
PMC4303849	1/2015	S34-PMC4303849	[', Osteopontin [18]); Cell Life and Death (comprising Proliferation, Differentiation, migration and Apoptosis, i.e.']	N/A	N/A	[('PR_000011574', "2'-5'-oligoadenylate synthase 1", 2, 'osteopontin'), ('GO_0008219', 'cell death', 21, 'cell life ... death'), ('GO_0008283', 'cell proliferation', 53, 'proliferation'), ('GO_0030154', 'cell differentiation', 68, 'differentiation'), ('GO_0006915', 'apoptotic process', 99, 'apoptosis')]
PMC4377888	3/2015	S213-PMC4377888	['furthermore, offspring had increased Renal Apoptosis combined with reduced Glomerular number.']	N/A	N/A	[('GO_0006281', 'DNA repair', 37, 'renal'), ('UBERON_0002113', 'kidney', 37, 'renal'), ('GO_0006915', 'apoptotic process', 43, 'apoptosis'), ('UBERON_0000074', 'renal glomerulus', 75, 'glomerular')]
PMC4379001	3/2015	S104-PMC4379001	['the Expression of Siah1B is induced by P53 during Apoptosis and tumor reversion, and the Siah1B Gene is a direct transcriptional target of P53 [24,25].']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('PR_000014662', 'selenoprotein W', 18, 'Siah1b'), ('PR_000003035', 'cellular tumor antigen p53', 39, 'p53'), ('GO_0006915', 'apoptotic process', 50, 'apoptosis'), ('PR_000014662', 'selenoprotein W', 89, 'Siah1b'), ('SO_0000704', 'gene', 96, 'gene'), ('PR_000003035', 'cellular tumor antigen p53', 139, 'p53')]
PMC4386645	3/2015	S58-PMC4386645	['moreover, ultrastructural changes on a cellular level, such as appearance of Membrane-bound Autophagic Vacuoles, Pyknotic Nuclei, and dilated Nuclear Periphery can be observed in zinc deficient Rats [31].']	N/A	N/A	[('GO_0016020', 'membrane', 77, 'membrane'), ('GO_0005776', 'autophagosome', 92, 'autophagic vacuoles'), ('GO_0006915', 'apoptotic process', 92, 'autophagic'), ('GO_0030263', 'apoptotic chromosome condensation', 113, 'pyknotic'), ('GO_0005634', 'nucleus', 122, 'nuclei'), ('GO_0034399', 'nuclear periphery', 142, 'nuclear periphery'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 194, 'rats')]
PMC4392553	3/2015	S373-PMC4392553	['the accumulation of Bile Acids in the cholestatic Liver induces oxidative stress and Apoptosis, resulting in damage to the Liver Parenchyma, and, ultimately, Extrahepatic Tissues as well.']	N/A	N/A	[('CHEBI_3098', 'bile acid', 20, 'bile acids'), ('UBERON_0001970', 'bile', 20, 'bile'), ('UBERON_0002107', 'liver', 50, 'liver'), ('GO_0006915', 'apoptotic process', 85, 'apoptosis'), ('UBERON_0001280', 'liver parenchyma', 123, 'liver parenchyma'), ('UBERON_0005292', 'extraembryonic tissue', 158, 'extrahepatic tissues')]
PMC4392553	3/2015	S529-PMC4392553	['Aging Of the mn-bound version of prion Proteins leads to loss of function.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 0, 'Aging of ... proteins')]
PMC4413804	5/2015	S23-PMC4413804	['spontaneous Abortions occurred in 61 (14.4%) of the 423 prospective Pregnancy cases.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 12, 'abortions'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy')]
PMC4417995	4/2015	S18-PMC4417995	['this Compound subsequently activates the Vitamin D receptor (vdr), Regulating the Expression of Genes involved in Calcium Metabolism, Proliferation, differentiation, Apoptosis, and Adaptive Immunity [9].']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 5, 'compound'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0065007', 'biological regulation', 67, 'regulating'), ('GO_0010467', 'gene expression', 82, 'expression'), ('SO_0000704', 'gene', 96, 'genes'), ('CHEBI_22313', 'alkaline earth metal atom', 114, 'calcium'), ('GO_0018884', 'carbazole metabolic process', 114, 'calcium metabolism'), ('GO_0008283', 'cell proliferation', 134, 'proliferation'), ('GO_0006915', 'apoptotic process', 166, 'apoptosis'), ('GO_0051866', 'general adaptation syndrome', 181, 'adaptive immunity')]
PMC4425955	4/2015	S13-PMC4425955	['Expression of Angiotensin Receptor Type 2 (Agtr2) is upregulated in response to Renal injury (mcgrath and welham1999; vazquez et\xa0al.2005), promoting Tissue Remodeling via Proliferation and Apoptosis.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000001185', 'alpha-1D adrenergic receptor', 14, 'angiotensin receptor type 2'), ('PR_000001180', 'opsin-5', 43, 'AGTR2'), ('UBERON_0002113', 'kidney', 80, 'renal'), ('GO_0048771', 'tissue remodeling', 149, 'tissue remodeling'), ('UBERON_0000479', 'tissue', 149, 'tissue'), ('GO_0008283', 'cell proliferation', 171, 'proliferation'), ('GO_0006915', 'apoptotic process', 189, 'apoptosis')]
PMC4459664	4/2015	S47-PMC4459664	['enrolled women were visited weekly by trained female workers to ascertain Pregnancy outcomes (Live Births, stillbirths, induced Abortions, or Miscarriages).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0008610', 'lipid biosynthetic process', 94, 'live births'), ('GO_0006915', 'apoptotic process', 128, 'abortions'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 142, 'miscarriages')]
PMC4464209	6/2015	S25-PMC4464209	['methods\nthe maternal newborn health registry (mnhr) is a prospective, population-based Birth and Pregnancy Outcomes registry that was started in 2009 at communities in seven global network sites, including: argentina, guatemala, india (belgaum and nagpur), kenya, pakistan, and zambia.']	N/A	N/A	[('GO_0042756', 'drinking behavior', 87, 'birth ...'), ('GO_0006915', 'apoptotic process', 97, 'pregnancy outcomes')]
PMC4476607	1/2015	S129-PMC4476607	['for example, the combined insults of Prenatal Alcohol exposure and iron deficiency resulted in increased Cerebellar Apoptosis (Cell Death), reduced Myelin content, and greater impairments in Cerebellar-dependent Classical Eyeblink Conditioning compared with either insult alone (rufer et al.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 37, 'prenatal'), ('CHEBI_30879', 'alcohol', 46, 'alcohol'), ('UBERON_0002037', 'cerebellum', 105, 'cerebellar'), ('GO_0006915', 'apoptotic process', 116, 'apoptosis'), ('GO_0008219', 'cell death', 127, 'cell death'), ('UBERON_0000345', 'myelin', 148, 'myelin'), ('UBERON_0002037', 'cerebellum', 191, 'cerebellar'), ('GO_0009828', 'plant-type cell wall loosening', 212, 'classical eyeblink conditioning'), ('UBERON_0008716', 'hilum of kidney', 222, 'eyeblink')]
PMC4483650	6/2015	S88-PMC4483650	['hypoxic damage, both in the form of necrosis and Apoptosis, is evident in the Cerebellum, Brain Stem Nuclei, Basal Ganglia, hippocampus and Cortex [19].']	N/A	N/A	[('GO_0006915', 'apoptotic process', 49, 'apoptosis'), ('UBERON_0002037', 'cerebellum', 78, 'cerebellum'), ('UBERON_0002298', 'brainstem', 90, 'brain stem'), ('GO_0005634', 'nucleus', 101, 'nuclei'), ('UBERON_0002420', 'basal ganglion', 109, 'basal ganglia'), ('UBERON_0001851', 'cortex', 140, 'cortex')]
PMC4516488	9/2009	S61-PMC4516488	['caption (fig): figure 5\n\neffect of Vitamin D3On Trail-induced Apoptosis and Cell survival In a549 cells.']	N/A	N/A	[('CHEBI_63460', 'parkeol', 35, 'vitamin D3on'), ('PR_000017209', 'utrophin', 35, 'vitamin D3on'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 48, 'TRAIL'), ('GO_0006915', 'apoptotic process', 62, 'apoptosis'), ('GO_0007569', 'cell aging', 76, 'cell ... in')]
PMC4516488	9/2009	S63-PMC4516488	['Metabolic activity (as a measure of cell viability and Apoptosis [facs analysis] were determined.']	N/A	N/A	[('GO_0008152', 'metabolic process', 0, 'Metabolic'), ('GO_0006915', 'apoptotic process', 55, 'apoptosis')]
PMC4516488	9/2009	S82-PMC4516488	['Apoptosis was measured by facs (Propidium Iodide assay).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 0, 'Apoptosis'), ('CHEBI_51240', 'propidium iodide', 32, 'propidium iodide')]
PMC4516488	9/2009	S146-PMC4516488	['Cell Nuclei were visualized with Propidium Iodide and subjected to facs analysis to monitor late-stage Apoptosis, and mts Proliferation assays were performed to measure cell viability.']	N/A	N/A	[('GO_0005634', 'nucleus', 0, 'Cell nuclei'), ('CHEBI_51240', 'propidium iodide', 33, 'propidium iodide'), ('GO_0006915', 'apoptotic process', 103, 'apoptosis'), ('GO_0008283', 'cell proliferation', 122, 'proliferation')]
PMC4516488	9/2009	S147-PMC4516488	['treatment with Vitamin D3Alone did not have a significant effect on Apoptosis, as compared with vehicle-treated cells (fig.']	N/A	N/A	[('CHEBI_67894', 'uvaol', 15, 'vitamin D3alone'), ('GO_0006915', 'apoptotic process', 68, 'apoptosis')]
PMC4539876	7/2015	S214-PMC4539876	['there were 2 spontaneous Abortions and 1 fetal death.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 25, 'abortions')]
PMC4544362	7/2015	S57-PMC4544362	['caption (table-wrap): table 1\nbody mass index z-score in childhood and Adolescence, according to characteristics in childhood.variablen%bmi-for-age z-score 0 to 5 years oldpbmi-for-age z-score 10 to 17 years oldpmean95%cimean95%cisex\xa0\xa0\xa0\xa00.92\xa0\xa00.15\u2003male1,22450.90.140.08;0.21\xa00.190.09;0.22\xa0\u2003female1,18149.10.150.09;0.22\xa00.280.20;0.36\xa0Birth weight (g)\xa0\xa0\xa0\xa0< 0.01\xa0\xa0< 0.01\u2003≥ 4,0001436.90.560.39;0.73\xa00.470.26;0.69\xa0\u20033,000-3,9991,61967.60.220.17;0.28\xa00.300.23;0.38\xa0\u20032,500-2,99948320.1-0.05-0.14;0.03\xa00.01-0.12;0.15\xa0\u2003< 2,5001606.4-0.37-0.59;-0.15\xa0-0.00-0.26;0.25\xa0length-for-age at Birth (z-score)a\xa0\xa0< 0.01\xa0\xa00.01\u2003< -2 z-score27011.30.170.12;0.22\xa00.260.20;0.32\xa0\u2003≥ -2 z-score2,12488.7-0.06-0.21;0.08\xa00.03-0.15;0.22\xa0bmi-for-age (z-score) - preschool age\xa0\xa0\xa0\xa0\xa0< 0.01\u2003thinness (< -2 z-score)692.8\xa0\xa0\xa0-0.44-0.88;0.00\xa0\u2003adequate (≥ -2 to ≤ 1 z-score)1,85777.2\xa0\xa0\xa00.080.02;0.15\xa0\u2003overweight (> 1 to ≤ 2 z-score)37115.4\xa0\xa0\xa00.720.58;0.86\xa0\u2003obesity (> 2 z-score)1080.45\xa0\xa0\xa01.401.13;1.67\xa0height-for-age (z-score) - preschool age\xa0\xa00.21\xa0\xa00.11\u2003< -2 z-score2,25893.90.130.09;0.18\xa00.32-0.04;0.60\xa0\u2003≥ -2 z-score1466.10.310.04;0.60\xa00.140.09;0.18\xa0economic classb\xa0\xa0\xa0\xa0< 0.01\xa0\xa0< 0.01\u2003a (high-income)863.60.340.11;0.58\xa00.790.48;1.11\xa0\u2003b28912.00.12-0.02;0.26\xa00.440.25;0.62\xa0\u2003c1,01942.40.250.18;0.32\xa00.260.17;0.35\xa0\u2003d80733.50.04-0.03;0.12\xa00.170.07;0.28\xa0\u2003e (low-income)2048.50.02-0.12;0.16\xa0-0.17-0.35;0.02\xa0maternal schooling (years)c\xa0\xa00.22\xa0\xa0< 0.01\u2003≥ 122068.60.170.03;0.31\xa00.600.40;0.81\xa0\u20039 to 1163826.50.160.06;0.25\xa00.300.19;0.41\xa0\u20035 to 81,36356.70.160.10;0.22\xa00.150.07;0.23\xa0\u20030 to 41777.4-0.02-0.18;0.14\xa00.18-0.05;0.41\xa0breastfeeding\xa0\xa0\xa0\xa0< 0.01\xa0\xa0< 0.01\u2003any1,94580.90.170.14;0.20\xa00.260.22;0.30\xa0\u2003never46019.10.05-0.01;0.11\xa00.130.04;0.21\xa0maternal smoking during Pregnancy and at childhood\xa0\xa00.75\xa0\xa00.13\u2003during both periods2128.90.14-0.03;0.31\xa00.11-0.07;0.29\xa0\u2003only during Pregnancy592.50.18-0.14;0.50\xa00.700.19;1.22\xa0\u2003only during childhood763.10.290.03;0.55\xa00.27-0.02;0.56\xa0\u2003no smoking2,04285.50.150.10;0.19\xa00.240.17;0.30\xa0paternal smoking at childhoodc\xa0\xa0\xa0\xa00.03\xa0\xa00.49\u2003yes50125.60.250.14;0.35\xa00.210.07;0.34\xa0\u2003no1,45676.80.120.07;0.18\xa00.280.20;0.35\xa0\nano information for 11 children.']	N/A	N/A	[('GO_0048848', 'neurohypophysis morphogenesis', 71, 'adolescence'), ('GO_0007567', 'parturition', 333, 'Birth'), ('GO_0007567', 'parturition', 573, 'birth'), ('GO_0007565', 'female pregnancy', 1707, 'pregnancy'), ('GO_0006915', 'apoptotic process', 1814, 'pregnancy592')]
PMC4598849	10/2015	S90-PMC4598849	['Cord Blood 25-Hydoxyvitamin D\nCord Blood sample was collected immediately after Delivery and Anticoagulated by use of Sodium Heparin.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_67462', '3-epi-caryoptin', 11, '25-hydoxyvitamin D'), ('UBERON_0000948', 'heart', 30, 'Cord'), ('UBERON_0000178', 'blood', 35, 'blood'), ('GO_0007567', 'parturition', 80, 'delivery'), ('GO_0006915', 'apoptotic process', 93, 'anticoagulated'), ('CHEBI_28790', 'serotonin', 118, 'sodium heparin')]
PMC4663580	11/2015	S235-PMC4663580	['latency to peak amplitude is interpreted as a measure of sustained Attention [35,36,37,38,39].']	N/A	N/A	[('GO_0006915', 'apoptotic process', 67, 'attention')]
PMC4663588	11/2015	S417-PMC4663588	['however, during Pregnancy and through Apoptosis the original Β-Cells will be replaced by new Islet Cells that are more sensitive to Glucose and response during the acute first phase of Insulin Release [195].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 16, 'pregnancy'), ('GO_0006915', 'apoptotic process', 38, 'apoptosis'), ('CL_0002200', 'oxyphil cell of thyroid', 61, 'β-cells'), ('CL_0000129', 'microglial cell', 93, 'islet cells'), ('UBERON_0002533', 'post-anal tail bud', 93, 'islet'), ('CHEBI_17234', 'glucose', 132, 'glucose'), ('GO_0006880', 'intracellular sequestering of iron ion', 185, 'insulin release'), ('PR_000045358', 'insulin family protein', 185, 'insulin')]
PMC4663588	11/2015	S421-PMC4663588	['it also reduces the Proliferation Of the Islet Cells and increases Apoptosis [196,197,198,199,200].']	N/A	N/A	[('GO_0008283', 'cell proliferation', 20, 'proliferation of ... cells'), ('CL_0000129', 'microglial cell', 41, 'islet cells'), ('UBERON_0002533', 'post-anal tail bud', 41, 'islet'), ('GO_0006915', 'apoptotic process', 67, 'apoptosis')]
PMC4663588	11/2015	S427-PMC4663588	['it also resulted in downregulation of Β-Cell Proliferation and upregulation of Β-Cell Apoptosis in Rat offspring at 3 week of age [199].']	N/A	N/A	[('CL_0000623', 'natural killer cell', 38, 'β-cell'), ('GO_0008283', 'cell proliferation', 40, 'cell proliferation'), ('CL_0000623', 'natural killer cell', 79, 'β-cell'), ('GO_0006915', 'apoptotic process', 81, 'cell apoptosis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 99, 'rat')]
PMC4738402	11/2015	S40-PMC4738402	['biochemical determinations\npreparation of homogenates and Membranes, measurement of total muscarinic receptors and enzyme activities, and muscarinic receptor‐mediated Activation Of G‐Proteins were carried out as described previously (machova et\xa0al .2008).']	N/A	N/A	[('GO_0016020', 'membrane', 58, 'membranes'), ('GO_0006915', 'apoptotic process', 167, 'activation of G‐proteins')]
PMC4778993	2/2016	S60-PMC4778993	['caption (table-wrap): table 2\n\ncharacteristics of included studies\n\ncaption (table-wrap): table 3\n\nrisk-of-bias assessment of the included randomized controlled trials∗\n\nAtopic sensitization\nseventeen trials including 2947 children contributed atopic sensitization data for meta-analysis, shown in figure2.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 170, 'Atopic')]
PMC4873529	3/2016	S116-PMC4873529	['effects of maternal and offspring Obesogenic Feeding on a Grp78 and b Chop determined by western blot; n \u2009=\u20093–4 Animals per group\n\neffect of maternal and offspring obesogenic feeding on Autophagy regulators\nNafpd and Pancreatic Carcinogenesis are kept going by derangement of Proliferation, Apoptosis, Metabolism, and Autophagy [33].']	N/A	N/A	[('GO_0001503', 'ossification', 34, 'obesogenic'), ('GO_0007631', 'feeding behavior', 45, 'feeding'), ('PR_000008210', 'glutathione peroxidase 1', 58, 'GRP78'), ('CHEBI_63057', 'EHNA', 70, 'CHOP'), ('PR_000005439', 'charged multivesicular body protein 5', 70, 'CHOP'), ('NCBITaxon_33208', 'Metazoa', 112, 'animals'), ('GO_0006914', 'autophagy', 186, 'autophagy'), ('PR_000010990', 'N-alpha-acetyltransferase 16, NatA auxiliary subunit', 207, 'NAFPD'), ('GO_0009834', 'plant-type secondary cell wall biogenesis', 217, 'pancreatic carcinogenesis'), ('UBERON_0001264', 'pancreas', 217, 'pancreatic'), ('GO_0008283', 'cell proliferation', 276, 'proliferation'), ('GO_0006915', 'apoptotic process', 291, 'apoptosis'), ('GO_0008152', 'metabolic process', 302, 'metabolism'), ('GO_0006914', 'autophagy', 318, 'autophagy')]
PMC4873529	3/2016	S155-PMC4873529	['furthermore, Overexpression of Chop leads to Cell Cycle arrest or Apoptosis [23].']	N/A	N/A	[('GO_0007308', 'oocyte construction', 13, 'overexpression'), ('CHEBI_63057', 'EHNA', 31, 'CHOP'), ('PR_000005439', 'charged multivesicular body protein 5', 31, 'CHOP'), ('GO_0007049', 'cell cycle', 45, 'cell cycle'), ('GO_0006915', 'apoptotic process', 66, 'apoptosis')]
PMC4874157	5/2016	S114-PMC4874157	['fernandez liguori et al ,16van walderveen et al 21and sandberg-wollheim et al 22reported that high doses of Interferon Β increased spontaneous Abortions and incidence of major Birth defects (eg, down syndrome, hydrocephalus, abnormalities in the x Chromosome, etc).']	N/A	N/A	[('CHEBI_76163', 'isoxicam', 108, 'interferon β'), ('PR_000008918', 'interferon alpha-5', 108, 'interferon β'), ('GO_0006915', 'apoptotic process', 143, 'abortions'), ('GO_0007567', 'parturition', 176, 'birth'), ('GO_0000805', 'X chromosome', 248, 'chromosome')]
PMC4896250	4/2016	S208-PMC4896250	['an otherwise healthy 63-year-old woman who developed an Anaphylactic reaction in a public open-air bath, some five minutes after an Ant stung her Hip.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 56, 'anaphylactic'), ('NCBITaxon_33208', 'Metazoa', 132, 'ant'), ('UBERON_0001464', 'hip', 146, 'hip')]
PMC4896250	4/2016	S2120-PMC4896250	['in Mice, Whey-Ige, acute allergic skin responses, Mmcp-1 release, body temperature and Anaphylactic shock symptoms were determined upon oral challenge in 4 research centers.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 3, 'mice'), ('CHEBI_33290', 'food', 9, 'whey'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 14, 'IgE'), ('PR_000010103', 'endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase', 50, 'mMCP-1'), ('GO_0006915', 'apoptotic process', 87, 'anaphylactic')]
PMC4896250	4/2016	S2121-PMC4896250	['in the guinea pigs Anaphylactic shock symptoms upon intravenous challenge were measured as a single parameter at 1 center.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 19, 'anaphylactic')]
PMC4896250	4/2016	S3409-PMC4896250	['we report a case of Lung cancer patient who experienced two near-fatal Anaphylactic reactions that resulted from paclitaxel and multivitamin, separately.']	N/A	N/A	[('UBERON_0002048', 'lung', 20, 'lung'), ('GO_0006915', 'apoptotic process', 71, 'anaphylactic')]
PMC4896250	4/2016	S5785-PMC4896250	['Cytolytic Molecules in Cd8+T Cells upregulated by Smad4 deletion induced th1 Cell Apoptosis, which resulted in increased th2.']	N/A	N/A	[('GO_0012501', 'programmed cell death', 0, 'Cytolytic'), ('CHEBI_36357', 'polyatomic entity', 10, 'molecules'), ('PR_000005170', 'CD37 molecule', 23, 'CD8'), ('CL_0000084', 'T cell', 27, 'T cells'), ('PR_000000364', 'smad2', 50, 'Smad4'), ('GO_0006915', 'apoptotic process', 77, 'cell apoptosis')]
PMC4896250	4/2016	S7328-PMC4896250	['the Ascs Secrete a variety of autocrine/paracrine factors, called secretome, that protect Cells from Apoptotic Cell Death and Modulate Immune System.']	N/A	N/A	[('CL_0002561', 'outer root sheath cell', 4, 'ASCs'), ('GO_0046903', 'secretion', 9, 'secrete'), ('CL_0000573', 'retinal cone cell', 90, 'cells'), ('CL_0000445', 'apoptosis fated cell', 101, 'apoptotic cell'), ('GO_0006915', 'apoptotic process', 101, 'apoptotic cell death'), ('GO_0065007', 'biological regulation', 126, 'modulate'), ('UBERON_0002405', 'immune system', 135, 'immune system')]
PMC4896250	4/2016	S7414-PMC4896250	['we evaluated causal Food, symptom of recent Anaphylactic reaction, Serum Mite-specific Ige, adrenaline treatment for anaphylaxis.']	N/A	N/A	[('CHEBI_33290', 'food', 20, 'food'), ('GO_0006915', 'apoptotic process', 44, 'anaphylactic'), ('UBERON_0001977', 'blood serum', 67, 'serum'), ('NCBITaxon_10088', 'Mus <genus>', 73, 'mite'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 87, 'IgE')]
PMC4896250	4/2016	S7416-PMC4896250	['results: number of Adrenaline treatment for Anaphylactic reaction in asthmatic group was higher than those of non-asthmatic group significantly (p<0.05).']	N/A	N/A	[('CHEBI_2436', 'acronycidine', 19, 'adrenaline'), ('GO_0006915', 'apoptotic process', 44, 'anaphylactic')]
PMC4896250	4/2016	S7418-PMC4896250	['forty three (81%) of Anaphylactic reactions in asthmatic group induced by Milk, wheat and egg were higher than 19(51%) in non-asthmatic patients (p<0.01).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 21, 'anaphylactic'), ('UBERON_0001913', 'milk', 74, 'milk')]
PMC4896250	4/2016	S7420-PMC4896250	['conclusion: in asthmatic children, Anaphylactic reactions occurred frequently by accidental Ingestion of daily Foods, for example, Milk, wheat and egg.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 35, 'anaphylactic'), ('GO_0007631', 'feeding behavior', 92, 'ingestion'), ('CHEBI_33290', 'food', 111, 'foods'), ('UBERON_0001913', 'milk', 131, 'milk')]
PMC4896250	4/2016	S8639-PMC4896250	['during the process she experienced Anaphylactic reactions were successfully treated.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 35, 'anaphylactic')]
PMC4897523	10/2014	S50-PMC4897523	['the mothers had greater frequencies of threatened Abortions, Epidural caudal anesthesia use, labor induction, and labor duration of less than one hour.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 50, 'abortions'), ('UBERON_2000660', 'epural', 61, 'epidural')]
PMC4915063	6/2016	S174-PMC4915063	['Ccl28 , which encodes the Growth Factor Chemokine Ligand 28 [45], increases Placental Cell Apoptosis [46] and is downregulated in a variety of Human malignancies [47,48].']	N/A	N/A	[('PR_000001995', 'C-C motif chemokine 23', 0, 'CCL28'), ('PR_000001220', 'encephalopsin', 26, 'growth factor chemokine ligand 28'), ('CL_0002247', 'pleural macrophage', 76, 'placental cell'), ('UBERON_0001987', 'placenta', 76, 'placental'), ('GO_0006915', 'apoptotic process', 86, 'cell apoptosis'), ('NCBITaxon_9606', 'Homo sapiens', 143, 'human')]
PMC4977046	3/2016	S276-PMC4977046	['in that study, a low-dose (0.25, 0.5, and 1 μm) of Ato, an oxide of Inorganic Arsenic, greatly enhanced the viability of cultured Osteoblasts and promoted Collagen Synthesis and secretion, and a high-dose (5, 10, and 20 μm) of ato led to a significant reduction in Osteoblast viability and induced Osteoblast Apoptosis.']	N/A	N/A	[('CHEBI_16866', 'alizarin', 51, 'ATO'), ('CHEBI_35828', 'arsenic(3+)', 68, 'inorganic arsenic'), ('CL_0000062', 'osteoblast', 130, 'osteoblasts'), ('GO_0032964', 'collagen biosynthetic process', 155, 'collagen synthesis'), ('CL_0000062', 'osteoblast', 265, 'osteoblast'), ('CL_0000062', 'osteoblast', 298, 'osteoblast'), ('GO_0006915', 'apoptotic process', 309, 'apoptosis')]
PMC4995778	8/2016	S4-PMC4995778	['evaluations included spontaneous Abortions (<22\xa0weeks Gestational age), fetal losses (≥22\xa0weeks Gestational age), ectopic Pregnancies, elective or therapeutic terminations, stillbirths, Birth defects, and live births.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 33, 'abortions'), ('GO_0007565', 'female pregnancy', 54, 'gestational'), ('GO_0007565', 'female pregnancy', 96, 'gestational'), ('GO_0007565', 'female pregnancy', 122, 'pregnancies'), ('GO_0007567', 'parturition', 186, 'birth')]
PMC4995778	8/2016	S44-PMC4995778	['the rate of spontaneous Abortions was calculated by dividing the number of fetal losses at <22\xa0weeks Gestational age by the total number of Pregnancies.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 24, 'abortions'), ('GO_0007565', 'female pregnancy', 101, 'gestational'), ('GO_0007565', 'female pregnancy', 140, 'pregnancies')]
PMC4995778	8/2016	S81-PMC4995778	['in the 32 spontaneous Abortions observed, the mean Gestational age at enrollment was 5.5\xa0weeks (sd, 2.0\xa0weeks; range 4–13 weeks).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 22, 'abortions'), ('GO_0007565', 'female pregnancy', 51, 'gestational')]
PMC4995778	8/2016	S107-PMC4995778	['in these patients, the rate of spontaneous Abortions (14.3\xa0% [5 of 35]) was higher than that observed in the registry (9.0\xa0%).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 43, 'abortions')]
PMC4997411	8/2016	S3-PMC4997411	['Ovary samples were collected during the fetal (day 55 (g55) and day 90 of Gestation (g90)) and offspring (Prepuberty day 160 (d160) and age at puberty) period to detect Ovary Development, antioxidant status and Apoptosis Cells.']	N/A	N/A	[('UBERON_0000992', 'ovary', 0, 'Ovary'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('GO_0007128', 'meiotic prophase I', 106, 'prepuberty'), ('GO_0001568', 'blood vessel development', 169, 'ovary development'), ('UBERON_0000992', 'ovary', 169, 'ovary'), ('GO_0006915', 'apoptotic process', 211, 'apoptosis cells')]
PMC4997411	8/2016	S7-PMC4997411	['maternal hfd increased the Inhibitor of the Apoptosis-Related Gene Of B-Cell Lymphoma-2 ( bcl2 ) mrna Expression at g90 and d160, whereas, pro-apoptotic-related Gene Bcl -2 assaciated x protein ( bax ) was reduced.']	N/A	N/A	[('CHEBI_35222', 'inhibitor', 27, 'inhibitor'), ('GO_0006915', 'apoptotic process', 44, 'apoptosis'), ('PR_000003900', 'aldo-keto reductase family 1 member A1', 44, 'apoptosis-related gene of B-cell lymphoma-2'), ('SO_0000704', 'gene', 62, 'gene'), ('CL_0000236', 'B cell', 70, 'B-cell'), ('UBERON_0001790', 'outer plexiform layer of retina', 71, '-'), ('GO_0010467', 'gene expression', 102, 'expression'), ('SO_0000704', 'gene', 161, 'gene'), ('PR_000004591', 'beta-1,4-glucuronyltransferase 1', 166, 'bcl -2')]
PMC4997411	8/2016	S116-PMC4997411	['Ovarian Development and Apoptosis\nin european Porcine Ovaries, primordial follicles begin to form at approximately g55, and the primary follicle was first detected at g90.']	N/A	N/A	[('GO_0001568', 'blood vessel development', 0, 'Ovarian Development'), ('UBERON_0000992', 'ovary', 0, 'Ovarian'), ('GO_0006915', 'apoptotic process', 24, 'Apoptosis'), ('NCBITaxon_10088', 'Mus <genus>', 46, 'porcine'), ('UBERON_0000992', 'ovary', 54, 'ovaries')]
PMC4997411	8/2016	S168-PMC4997411	['the clusters undergo Apoptosis and break up, becoming enclosed in primordial follicles consisting of one Oocyte and several Somatic Granulosa Cells and transforming into the primary follicle [24].']	N/A	N/A	[('GO_0006915', 'apoptotic process', 21, 'apoptosis'), ('CL_0000023', 'oocyte', 105, 'oocyte'), ('CL_0002312', 'somatotroph', 124, 'somatic granulosa cells')]
PMC4999868	8/2016	S106-PMC4999868	['this approach results in 70% decrease in target protein Expression and a marked functional activation of Mtorc1 and 2 Signaling Pathways without affecting syncytialization, viability or Apoptosis35.']	N/A	N/A	[('GO_0010467', 'gene expression', 56, 'expression'), ('GO_0035196', 'production of miRNAs involved in gene silencing by miRNA', 105, 'mTORC1 ... signaling pathways'), ('GO_0006915', 'apoptotic process', 186, 'apoptosis35')]
PMC5000726	8/2016	S17-PMC5000726	['normally, in Adult Skeleton Bone Remodelling is maintained in a tight balance by highly Regulated differentiation, activity, and Apoptosis Of bone-forming Osteoblasts and bone-Resorbing Osteoclasts.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 13, 'adult'), ('UBERON_0004288', 'skeleton', 19, 'skeleton'), ('GO_0046849', 'bone remodeling', 28, 'bone remodelling'), ('GO_0065007', 'biological regulation', 88, 'regulated'), ('GO_0006915', 'apoptotic process', 129, 'apoptosis of ...'), ('CL_0000062', 'osteoblast', 155, 'osteoblasts'), ('GO_0060033', 'anatomical structure regression', 176, 'resorbing'), ('CL_0000092', 'osteoclast', 186, 'osteoclasts')]
PMC5021959	6/2016	S54-PMC5021959	['immunohistochemistry for Apoptosis\nRat pups were deeply anesthetized with a lethal dose of Sodium Pentobarbital, perfused transcardially with 0.9% heparinized-saline followed by a Fixative of 4% paraformaldehyde.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 25, 'apoptosis'), ('NCBITaxon_10088', 'Mus <genus>', 35, 'Rat'), ('CHEBI_7984', 'Pentobarbital sodium', 91, 'sodium pentobarbital'), ('CHEBI_50913', 'fixative', 180, 'fixative')]
PMC5025983	8/2015	S27-PMC5025983	['Fatty Acids consumed for nutrition have vital functions on energy Metabolism and energy storage; they take part in cell enlargement, promotion of cell functions, coordination of intra- and Extracellular communications, and Regulation of Genes that supply energy substrates and Control Cellular Responses to the Metabolic environment [20–22].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acids'), ('GO_0008152', 'metabolic process', 66, 'metabolism'), ('GO_0005576', 'extracellular region', 189, 'extracellular'), ('GO_0065007', 'biological regulation', 223, 'regulation'), ('SO_0000704', 'gene', 237, 'genes'), ('GO_0065007', 'biological regulation', 277, 'control'), ('GO_0006915', 'apoptotic process', 285, 'cellular responses'), ('GO_0008152', 'metabolic process', 311, 'metabolic')]
PMC5090877	11/2016	S256-PMC5090877	['caption (table-wrap): table 3\n\nkey factors associated with compliance to ≥90-day Uptake Of Micronutrients during Pregnancyfactors b s.e.walddfsig.exp( b )95\xa0% c.i.']	N/A	N/A	[('GO_0051402', 'neuron apoptotic process', 81, 'uptake of micronutrients'), ('CHEBI_33839', 'macromolecule', 91, 'micronutrients'), ('GO_0006915', 'apoptotic process', 113, 'pregnancyFactors')]
PMC5292192	1/2017	S37-PMC5292192	['when rodents are exposed to Choline deficiency during their fetal development, they show decreased Cell Division and increased Apoptosis in their hippocampus [20–22].']	N/A	N/A	[('CHEBI_15354', 'choline', 28, 'choline'), ('GO_0051301', 'cell division', 99, 'cell division'), ('GO_0006915', 'apoptotic process', 127, 'apoptosis')]
PMC5303734	2/2017	S108-PMC5303734	['Cell Apoptosis and dna fragmentation\nat 13 weeks, there was significant increase in Caspase-3 and tunel positive cell numbers in the Cortex of male se offspring compared with the Sham offspring ( p< 0.05, figures4d,h).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 0, 'Cell Apoptosis'), ('PR_000002319', 'catenin beta-1 isoform 1', 84, 'caspase-3'), ('UBERON_0001851', 'cortex', 133, 'cortex'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 179, 'SHAM')]
PMC5303734	2/2017	S198-PMC5303734	['Autophagy is known to block Caspase-3 dependent Apoptosis, a marker for cell injury (mariño et al.,2014).']	N/A	N/A	[('GO_0006367', 'transcription initiation from RNA polymerase II promoter', 0, 'Autophagy'), ('PR_000002319', 'catenin beta-1 isoform 1', 28, 'caspase-3'), ('GO_0006915', 'apoptotic process', 48, 'apoptosis')]
PMC5307851	2/2017	S156-PMC5307851	['Plasma, buffy coat and Anticoagulated Rbcs will be separated by centrifugation (3000×g, 10\xa0min, 4\xa0°c).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('GO_0006915', 'apoptotic process', 23, 'anticoagulated'), ('CL_0000232', 'erythrocyte', 38, 'RBCs')]
PMC5332195	8/2016	S157-PMC5332195	['Prr5L also promotes Apoptosis via activation of the pro-inflammatory cytokine, tumor necrosis factor alpha (tnfα) (thedieck et al.']	N/A	N/A	[('PR_000013319', 'neurotrypsin', 0, 'PRR5L'), ('GO_0006915', 'apoptotic process', 20, 'apoptosis')]
PMC5332602	3/2017	S269-PMC5332602	['the frequencies and Tissue distribution of Apoptotic Mncs were assessed with Annexin V Apoptosis detection kit Apc (ebioscience, san diego, ca)/Propidium Iodide staining Solution (ebioscience).']	N/A	N/A	[('UBERON_0000479', 'tissue', 20, 'tissue'), ('CL_0000445', 'apoptosis fated cell', 43, 'apoptotic'), ('CL_0000485', 'mucosal type mast cell', 53, 'MNCs'), ('PR_000004077', 'annexin A4', 77, 'annexin V'), ('GO_0006915', 'apoptotic process', 87, 'Apoptosis'), ('PR_000004122', 'adenomatous polyposis coli protein', 111, 'APC'), ('CHEBI_51240', 'propidium iodide', 144, 'propidium iodide'), ('CHEBI_75958', 'solution', 170, 'solution')]
PMC5415431	11/2016	S107-PMC5415431	['fish and Processed Food Consumption by cp trajectory\n\ncaption (table-wrap): table 1\n\nmaternal and child sample characteristicseoplow cpdifferenceamaternal and Birth characteristics%n/n%n/nχ2\u2003ethnicity (caucasian/white)98.1635 / 64798.64891 / 49610.78\u2003offspring sex (male)56.9379 / 66649.02478 / 506114.86***\u2003multiparity67.3439 / 65264.03194 / 49932.84\u2003social class: low-sesb14.373 / 5258.4364 / 434417.50***Prenatal and Birth risk factors\u2003ever smoked during Pregnancy30.9203 / 65616.0799 / 500189.09***\u2003Preterm (<37\xa0weeks Gestation)c3.6024 / 6664.35220 / 50610.80\u2003low Birth weight (<2500\xa0g)c3.2021 / 6563.46173 / 50010.12\u2003presence of Birth complications22.7136 / 59919.6903 / 46183.30\u2003never Breastfed (first 6\xa0months)20.1133 / 52915.3771 / 503910.06**\u2003early parenthoodd7.449 / 6663.6184 / 506120.89***contextual risk factors (Prenatal-4\xa0years)\u2003inadequate housing21.5143 / 66610.9553 / 506061.26***\u2003lack of basic living conditions9.362 / 6667.1360 / 50574.18*\u2003housing defects/infestations32.2214 / 66626.01313 / 505911.65**\u2003no educational qualificationse18.1117 / 6489.0451 / 498851.42***\u2003financial difficulties30.3201 / 66417.4877 / 505464.02***\u2003partner status (no partner)20.0133 / 66513.2667 / 506022.73***\u2003lack of partner affection40.6263 / 64717.8891 / 4995183.20***\u2003partner cruelty38.0253 / 66617.7894 / 5059151.63***\u2003major family problems3.322 / 6663.0150 / 50610.22\u2003large family size (>3 children)9.261 / 6656.4322 / 50617.45**\u2003maternal psychopathology55.7371 / 66628.41437 / 5061203.22***\u2003substance usee, f26.9179 / 66620.01010 / 506117.13***\u2003trouble with policee11.778 / 6664.9248 / 505950.82***\u2003criminal convictionse1.812 / 6660.944 / 50595.28*child behavioural characteristicsgmean\xa0±\xa0sdn/nmean\xa0±\xa0sdn/nfemotional difficulties\u2003childhood (4-10y)2.47\xa0±\xa01.56666 / 6661.28\xa0±\xa01.175061 / 5061558.88***\u2003early Adolescence (12-13y)2.63\xa0±\xa02.03621 / 6661.15\xa0±\xa01.344797 / 5061587.72***hyperactivity\u2003childhood (4-10y)5.49\xa0±\xa02.13666 / 6662.81\xa0±\xa01.685061 / 50611402.50***\u2003early Adolescence (12-13y)5.27\xa0±\xa02.38620 / 6662.27\xa0±\xa01.734797 / 50611491.33***\neop early-onset persistent conduct problems, low cp low conduct problems, n number with reported adversity, n total number with data available, sd standard deviation, ses socioeconomic status\n* p \xa0<\xa00.05; ** p \xa0<\xa00.01; *** p \xa0<\xa00.001\nadf\xa0=\xa01 (pearson”s chi-square; f-values)\nbclasses iv and v (registrar general”s social class scale, surveys 1991)\ncword health organization\nddefined as first Pregnancy <17\xa0years or first Birth <20\xa0years\nemother or partner\nfincludes Alcohol, illicit drug use, and more than two alcoholic drinks/day\ngmean scores (parent-reported, 10-point scale), strengths and difficulties questionnaire\nmean weekly servings of fish and processed Food for eop and low cp trajectories (Prenatal, 3\xa0years) along with overall group differences (f-statistics) are shown in table2.']	N/A	N/A	[('GO_0019688', 'purine deoxyribonucleoside interconversion', 9, 'Processed Food Consumption'), ('CHEBI_33290', 'food', 19, 'Food'), ('GO_0007567', 'parturition', 159, 'birth'), ('GO_0007565', 'female pregnancy', 407, 'Prenatal'), ('GO_0007567', 'parturition', 420, 'birth'), ('GO_0006915', 'apoptotic process', 458, 'pregnancy30'), ('GO_0007128', 'meiotic prophase I', 503, 'Preterm'), ('GO_0007565', 'female pregnancy', 522, 'gestation'), ('GO_0007567', 'parturition', 568, 'birth'), ('GO_0007567', 'parturition', 634, 'birth'), ('GO_0007567', 'parturition', 691, 'breastfed'), ('GO_0007565', 'female pregnancy', 826, 'prenatal'), ('GO_0044808', 'oncostatin M production', 1811, 'Adolescence'), ('GO_0044808', 'oncostatin M production', 1972, 'Adolescence'), ('GO_0007565', 'female pregnancy', 2437, 'pregnancy'), ('GO_0007567', 'parturition', 2466, 'birth'), ('CHEBI_30879', 'alcohol', 2511, 'alcohol'), ('CHEBI_33290', 'food', 2709, 'food'), ('GO_0007565', 'female pregnancy', 2747, 'prenatal')]
PMC5417583	5/2017	S154-PMC5417583	['dietary Intake of Nicotinamide, Nicotinamide-riboside, and Nicotinamide mononucleotide improves Metabolic health and restores Mitochondrial function whether measured by Respiration, Membrane Potential, Atp Production Apoptosis, Autophagy, or the unfolded response with less degeneration and more active Stem Cells.358supplementation works for Genetic versions of premature Ageing and defects in Dna Repair with resulting Sirt inactivation.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 8, 'intake'), ('CHEBI_17154', 'nicotinamide', 18, 'nicotinamide'), ('CHEBI_17154', 'nicotinamide', 32, 'nicotinamide'), ('CHEBI_17154', 'nicotinamide', 59, 'nicotinamide'), ('GO_0008152', 'metabolic process', 96, 'metabolic'), ('GO_0005739', 'mitochondrion', 126, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 169, 'respiration'), ('GO_0045121', 'membrane raft', 182, 'membrane potential'), ('GO_0006754', 'ATP biosynthetic process', 202, 'ATP production'), ('GO_0006915', 'apoptotic process', 217, 'apoptosis'), ('GO_0006914', 'autophagy', 228, 'autophagy'), ('CL_0000034', 'stem cell', 303, 'stem cells'), ('SO_0000704', 'gene', 343, 'genetic'), ('GO_0007568', 'aging', 373, 'ageing'), ('GO_0006281', 'DNA repair', 395, 'DNA repair'), ('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 421, 'SIRT')]
PMC5424401	10/2015	S381-PMC5424401	['patients with hps suffer spontaneous Abortions at higher rates than Intrauterine-only Pregnancies (up to 30\xa0%) [18].']	N/A	N/A	[('GO_0006915', 'apoptotic process', 37, 'abortions'), ('UBERON_0022293', 'reproductive gland secretion', 68, 'intrauterine'), ('GO_0007565', 'female pregnancy', 86, 'pregnancies')]
PMC5433134	5/2017	S6-PMC5433134	['logistic regression analyses were adjusted for age, parity, Planning Of Pregnancy, education and norwegian language skills.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 60, 'planning of pregnancy')]
PMC5433134	5/2017	S68-PMC5433134	['overall ethnic differences in the crude percentages of Folic Acid supplement use were tested using two-sided χ2–test, separately among all women and stratified by educational level and Planning Of Pregnancy.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 55, 'folic acid'), ('GO_0006915', 'apoptotic process', 185, 'planning of pregnancy')]
PMC5433134	5/2017	S71-PMC5433134	['adjusted models were carried out using enter-method, adjusting simultaneously for age, parity, Planning Of Pregnancy and educational level (model 1).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 95, 'planning of pregnancy')]
PMC5433134	5/2017	S77-PMC5433134	['the product terms ethnicity*Planning Of Pregnancy and ethnicity*education were added to each regression model (model 2) one by one.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 28, 'planning of pregnancy')]
PMC5433134	5/2017	S78-PMC5433134	['Planning Of Pregnancy did not modify the association between ethnicity and Supplement use before or during Pregnancy ( p \u2009=\u20090.31 and p \u2009=\u20090.89, respectively, for the product terms).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 0, 'Planning of pregnancy'), ('CHEBI_16158', 'steroid sulfate', 75, 'supplement'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy')]
PMC5433134	5/2017	S101-PMC5433134	['among all women and stratified by educational level and Planning Of Pregnancy, crude percentages\ncompared with european women, all other ethnic groups had decreased odds for using the supplements in the unadjusted logistic regressions (table\xa02).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 56, 'planning of pregnancy')]
PMC5433134	5/2017	S108-PMC5433134	['adjusted model 1 included ethnicity, age, parity, Planning Of Pregnancy and educational level.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 50, 'planning of pregnancy')]
PMC5433134	5/2017	S124-PMC5433134	['adjusted model 1 included ethnicity, age, parity, Planning Of Pregnancy and educational level.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 50, 'planning of pregnancy')]
PMC5445052	4/2017	S124-PMC5445052	['immediately after Birth, selected Oocytes undergo a wave of Apoptosis, and surplus surviving Oocytes form the primordial follicle pool; the entire process is completed within 4\xa0days of the Postnatal period [38].']	N/A	N/A	[('GO_0007567', 'parturition', 18, 'birth'), ('CL_0000023', 'oocyte', 34, 'oocytes'), ('GO_0006915', 'apoptotic process', 60, 'apoptosis'), ('CL_0000023', 'oocyte', 93, 'oocytes'), ('GO_0007567', 'parturition', 189, 'postnatal')]
PMC5445671	6/2017	S38-PMC5445671	['maternal parity was computed with the use of questionnaire data that were collected at booking as the number of Deliveries (i.e., alive children, dead children, and still Births) with the exclusion of Abortions.']	N/A	N/A	[('GO_0007567', 'parturition', 112, 'deliveries'), ('GO_0007567', 'parturition', 171, 'births'), ('GO_0006915', 'apoptotic process', 201, 'abortions')]
PMC5448387	11/2016	S35-PMC5448387	[')a21.7 (1.2)Prepregnancy bmi category (no., %)underweight/normal (<25)48 (29%)overweight (25‐29)45 (27%)obese (≥30)64 (39%)missing7 (4%)Prepregnancy bmi (kg/m2)a29.9 (7.5)bmi 20–24\xa0weeks (kg/m2)a31.28 (6.92)smoking (%)never24 (15%)past16 (10%)any during Pregnancy90 (55%)missing35 (21%)education (%)<h.s.61 (37%)h.s.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'Prepregnancy'), ('GO_0007565', 'female pregnancy', 136, 'PrePregnancy'), ('GO_0006915', 'apoptotic process', 254, 'pregnancy90')]
PMC5470056	4/2017	S101-PMC5470056	['Optogenetic silencing of pmsis elongated the motor burst duration.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 0, 'Optogenetic')]
PMC5470056	4/2017	S242-PMC5470056	['Memory-Guided behavior\nLarvae are capable of forming Associative Memory [148].']	N/A	N/A	[('GO_0007613', 'memory', 0, 'Memory'), ('GO_0051318', 'G1 phase', 7, 'Guided'), ('NCBITaxon_10088', 'Mus <genus>', 23, 'Larvae'), ('GO_0006915', 'apoptotic process', 53, 'associative'), ('GO_0007613', 'memory', 65, 'memory')]
PMC5470056	4/2017	S248-PMC5470056	['by assembling the reciprocal Associative data, the Memory-related component is extracted [75].']	N/A	N/A	[('GO_0006915', 'apoptotic process', 29, 'associative'), ('GO_0007613', 'memory', 51, 'memory')]
PMC5489519	6/2017	S21-PMC5489519	['Tumor Necrosis Factor (Tnf)-Related Apoptosis Inducing Ligand (Trail) is a member of the Tnf superfamily18.']	N/A	N/A	[('PR_000016333', 'tigger transposable element-derived protein 3', 0, 'Tumor necrosis factor ...'), ('PR_000000035', 'BMP receptor type-1A', 23, 'TNF)-related apoptosis inducing ligand'), ('GO_0006915', 'apoptotic process', 36, 'apoptosis'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 63, 'TRAIL'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 89, 'TNF')]
PMC5489519	6/2017	S25-PMC5489519	['Trail functions through death receptors Dr4, Dr5 which promote Apoptosis and also binds to Dcr1, Dcr2 receptors that lack a death Domain21.']	N/A	N/A	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 0, 'TRAIL'), ('PR_000001177', 'D(2) dopamine receptor', 40, 'DR4'), ('PR_000001177', 'D(2) dopamine receptor', 45, 'DR5'), ('GO_0006915', 'apoptotic process', 63, 'apoptosis'), ('PR_000001177', 'D(2) dopamine receptor', 91, 'DcR1'), ('PR_000001179', 'D(4) dopamine receptor', 97, 'DcR2'), ('SO_0000417', 'polypeptide_domain', 130, 'domain21')]
PMC5579643	8/2017	S59-PMC5579643	['it stimulates Innate Immune Responses by enhancing the Chemotactic and Phagocytotic Responses of Macrophages, as well as the Production Of Antimicrobial Proteins such as Cathelicidin.']	N/A	N/A	[('GO_0044419', 'biological process involved in interspecies interaction between organisms', 14, 'innate immune responses'), ('UBERON_0002405', 'immune system', 21, 'immune'), ('GO_0006260', 'DNA replication', 55, 'chemotactic ...'), ('GO_0006915', 'apoptotic process', 71, 'phagocytotic responses'), ('CL_0000235', 'macrophage', 97, 'macrophages'), ('GO_0006412', 'translation', 125, 'production of ... proteins'), ('CHEBI_65381', 'albizoside C', 139, 'antimicrobial'), ('PR_000006009', 'alpha-catulin', 170, 'cathelicidin')]
PMC5634437	10/2017	S11-PMC5634437	['thousands of Pregnant women began taking the Drug resulting in a dramatic increase in spontaneous Abortions (i.e., ‘Miscarriages’), and congenital abnormalities2.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'pregnant'), ('CHEBI_23888', 'drug', 45, 'drug'), ('GO_0006915', 'apoptotic process', 98, 'abortions'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 116, 'miscarriages')]
PMC5644840	4/2014	S121-PMC5644840	['Glucocorticoids and 11β-Hsd Inhibitors advanced Apoptosis in the term Placenta [119].']	N/A	N/A	[('CHEBI_5439', 'Glutethimide', 0, 'Glucocorticoids'), ('CHEBI_80089', 'Coronafacic acid', 23, '-HSD inhibitors'), ('PR_000009258', 'potassium voltage-gated channel subfamily E member 4', 23, '-HSD'), ('GO_0006915', 'apoptotic process', 48, 'apoptosis'), ('UBERON_0001987', 'placenta', 70, 'placenta')]
PMC5688482	11/2017	S38-PMC5688482	['in this practice, teams of health professionals meet with women in “before and after” appointments to advise and follow up on Abortions that take place outside the clinic, with the use of Misoprostol that the women procure on their own.']	N/A	N/A	[('GO_0006915', 'apoptotic process', 126, 'abortions'), ('CHEBI_63610', 'misoprostol', 188, 'misoprostol')]
PMC5690443	12/2015	S122-PMC5690443	['mg deficiency promotes Apoptosis In Cardiovascular Cells, oxidative stress, and dna damage[53].']	N/A	N/A	[('GO_0006915', 'apoptotic process', 23, 'apoptosis in ... cells'), ('CL_0002072', 'nodal myocyte', 36, 'cardiovascular cells'), ('UBERON_0004535', 'cardiovascular system', 36, 'cardiovascular')]
PMC5804559	10/2017	S98-PMC5804559	['caption (table-wrap): table 5:\n\na functional annotation comparison of up and downregulated Genes at each generationf0f1f2f3go categorygo term n \u2009=\u20091074 n \u2009=\u20091867 n \u2009=\u2009541 n \u2009=\u20091684 n \u2009=\u200917 n \u2009=\u200922 n \u2009=\u20091893 n \u2009=\u20092720↑ Expression in hplc↓ Expressison in hplc↓ Expression in mm↑ Expression in mm↓ Expression in mm↑ Expression in mm↓ Expression in mm↑ Expression in mm Biological Process# Genes % of total # Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes % of total\u2003biological adhesiongo: 002261030.30341.9010.20291.9017.1070.40351.50\u2003biological Regulationgo: 0065007807.601277.00255.101097.2014.501437.501757.40\u2003cellular component organization or biogenesisgo: 0071840938.90633.50367.30513.4014.501769.20984.10\u2003Cellular processgo: 000998737035.3047526.3016433.5038325.50214.30418.2069636.3060225.50\u2003developmental processgo: 0032502373.501045.80112.20895.9029.10703.601476.20\u2003Immune System processgo: 0002376101.00261.4051.00251.70160.80331.40\u2003localizationgo: 0051179787.401397.70255.101308.60214.3029.101517.901948.20\u2003Locomotiongo: 004001140.4010.1020.4010.1060.3010.00\u2003Metabolic processgo: 000815238336.5039321.8017936.5032821.80535.70522.7070836.9050821.50\u2003multicellular Organismal processgo: 0032501181.701277.0061.20906.0029.10281.501626.90\u2003reproductiongo: 0000003161.50301.7091.80241.6014.50281.50361.50\u2003response to stimulusgo: 0050896757.201246.90336.701067.0014.501407.301667.00\u2003Rhythmic processgo: 0048511140.8010.20130.9014.5010.10140.60 protein class# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total \u2003Calcium-Binding proteinpc0006040.40271.5010.20140.90170.90351.50\u2003Cell Adhesion Moleculepc0006920.20241.30161.1050.30301.30\u2003Cell Junction proteinpc0007030.30%80.40100.7050.30140.60\u2003chaperonepc0007280.80%30.2020.40%30.20140.7070.30\u2003Cytoskeletal proteinpc00085413.90%442.40173.50%382.50593.10592.50\u2003defense/immunity proteinpc0009020.20%80.4010.20%70.5070.40100.40\u2003enzyme modulatorpc00095424.00%593.30142.90%513.4014.50%1015.30723.00\u2003Extracellular Matrix proteinpc00102221.20161.1030.20261.10\u2003hydrolasepc00121737.00%1448.00306.10%1318.70428.60%29.10%1427.401817.70\u2003isomerasepc0013550.50%50.3080.50130.7070.30\u2003ligasepc00142242.30%201.1081.60%151.0017.10%14.50%482.50251.10\u2003lyasepc0014440.40%281.60201.30150.80251.10\u2003Membrane Traffic proteinpc0015060.60%160.90151.00140.70210.90\u2003Nucleic Acid bindingpc0017116415.60%724.008818.00%604.0029615.401345.70\u2003oxidoreductasepc00176212.00%945.20122.40%674.50432.20964.10\u2003receptorpc00197121.10%814.5051.00%644.3017.10%281.501074.50\u2003signalling Moleculepc00207121.10%563.1030.60%493.3014.50%241.30723.00\u2003storage proteinpc0021030.30%70.4020.40%40.3050.3080.30\u2003structural proteinpc0021120.2020.1010.2030.2070.4030.10\u2003transcription factorpc00218817.70683.80336.70%593.901306.801175.00\u2003transfer/carrier proteinpc00219131.20%362.0010.20%312.10281.50512.20\u2003transferasepc00220625.90%563.10255.10%493.3014.50%1316.80662.80\u2003Transmembrane receptor Regulatory/adaptor proteinpc0022610.10%60.3081.60%40.3030.2050.20\u2003transporterpc00227282.70%1407.801087.20472.501687.10\u2003Viral proteinpc0023710.10 molecular function# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total \u2003antioxidant activitygo: 001620920.2090.5030.6070.5050.30120.50\u2003bindinggo: 000548825824.6024013.3011723.9020113.4017.10%14.50%45523.7034914.80\u2003catalytic activitygo: 000382426525.3041222.8012325.1035223.40%535.70%418.20%52427.3048320.40\u2003channel regulator activitygo: 001624710.00\u2003receptor activitygo: 000487280.80543.0051.00473.1017.10180.90743.10\u2003signal transducer activitygo: 000487130.30120.7010.2080.5070.40190.80\u2003structural Molecule activitygo: 0005198222.10643.5061.20442.90452.30873.70\u2003Translation regulator activitygo: 004518220.2010.1010.201157.6090.5030.10\u2003transporter activitygo: 0005215343.201498.30132.7017.1014.50583.001777.50\nup- and down-regulated Genes at each generation were submitted to panther for an analysis of their annotated function.']	N/A	N/A	[('SO_0000704', 'gene', 91, 'genes'), ('GO_0010467', 'gene expression', 218, 'expression'), ('GO_0010467', 'gene expression', 238, 'expressison'), ('GO_0010467', 'gene expression', 259, 'expression'), ('GO_0010467', 'gene expression', 277, 'expression'), ('GO_0010467', 'gene expression', 295, 'expression'), ('GO_0010467', 'gene expression', 313, 'expression'), ('GO_0010467', 'gene expression', 331, 'expression'), ('GO_0010467', 'gene expression', 349, 'expression'), ('GO_0006915', 'apoptotic process', 366, 'Biological process'), ('SO_0000704', 'gene', 386, 'genes'), ('SO_0000704', 'gene', 405, 'genes'), ('SO_0000704', 'gene', 422, 'genes'), ('SO_0000704', 'gene', 439, 'genes'), ('SO_0000704', 'gene', 456, 'genes'), ('SO_0000704', 'gene', 473, 'genes'), ('SO_0000704', 'gene', 490, 'genes'), ('SO_0000704', 'gene', 507, 'genes'), ('GO_0050818', 'regulation of coagulation', 604, 'regulationGO'), ('GO_0007049', 'cell cycle', 770, 'Cellular'), ('UBERON_0002410', 'autonomic nervous system', 934, 'Immune system'), ('GO_0061440', 'kidney vasculature development', 1077, 'LocomotionGO'), ('GO_0008152', 'metabolic process', 1129, 'Metabolic'), ('NCBITaxon_1', 'root', 1232, 'organismal'), ('GO_0046334', 'octopamine catabolic process', 1445, 'Rhythmic'), ('SO_0000704', 'gene', 1521, 'genes'), ('SO_0000704', 'gene', 1538, 'genes'), ('SO_0000704', 'gene', 1555, 'genes'), ('SO_0000704', 'gene', 1572, 'genes'), ('SO_0000704', 'gene', 1589, 'genes'), ('SO_0000704', 'gene', 1606, 'genes'), ('SO_0000704', 'gene', 1623, 'genes'), ('SO_0000704', 'gene', 1640, 'genes'), ('CHEBI_31341', 'calcium dihydroxide', 1657, 'Calcium'), ('PR_000010000', 'lysozyme g-like protein 2', 1664, '-binding'), ('PR_000009339', 'killer cell immunoglobulin-like receptor 3DL3', 1722, 'Cell adhesion moleculePC0006920'), ('CHEBI_53706', 'phenoxymethylpenicillanyl group', 1736, 'moleculePC0006920'), ('GO_0030054', 'cell junction', 1780, 'Cell junction'), ('GO_0005856', 'cytoskeleton', 1887, 'Cytoskeletal'), ('GO_0031012', 'extracellular matrix', 2087, 'Extracellular matrix'), ('GO_0016020', 'membrane', 2368, 'Membrane'), ('GO_0055085', 'transmembrane transport', 2368, 'Membrane traffic'), ('CHEBI_17497', 'glycolic acid', 2430, 'Nucleic acid'), ('GO_0005634', 'nucleus', 2430, 'Nucleic'), ('CHEBI_53726', 'procion red MX-5B', 2633, 'moleculePC00207121'), ('GO_0032588', 'trans-Golgi network membrane', 3003, 'Transmembrane'), ('GO_0065007', 'biological regulation', 3026, 'regulatory'), ('NCBITaxon_10088', 'Mus <genus>', 3145, 'Viral'), ('SO_0000704', 'gene', 3191, 'genes'), ('SO_0000704', 'gene', 3208, 'genes'), ('SO_0000704', 'gene', 3225, 'genes'), ('SO_0000704', 'gene', 3242, 'genes'), ('SO_0000704', 'gene', 3259, 'genes'), ('SO_0000704', 'gene', 3276, 'genes'), ('SO_0000704', 'gene', 3293, 'genes'), ('SO_0000704', 'gene', 3310, 'genes'), ('CHEBI_36357', 'polyatomic entity', 3754, 'molecule'), ('GO_0006412', 'translation', 3818, 'Translation'), ('SO_0000704', 'gene', 3989, 'genes')]
PMC5812027	2/2018	S46-PMC5812027	['Pregnancy loss was defined as both spontaneous Abortions from Gestational week 4 and Intrauterine fetal death (iufd).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('GO_0006915', 'apoptotic process', 47, 'abortions'), ('GO_0007565', 'female pregnancy', 62, 'gestational'), ('UBERON_0022293', 'reproductive gland secretion', 85, 'intrauterine')]
PMC5828098	2/2018	S27-PMC5828098	['symptoms include reduced frequency of Defecation, occurrence of faecal incontinence, stool retention, painful or hard Bowel Movements, or large diameter Stools.']	N/A	N/A	[('GO_0030421', 'defecation', 38, 'defecation'), ('UBERON_0000160', 'intestine', 118, 'bowel'), ('GO_0006915', 'apoptotic process', 124, 'movements'), ('UBERON_0000945', 'stomach', 153, 'stools')]
PMC5906686	4/2018	S56-PMC5906686	['at the same time, the Bax/Bcl-2 ratio, evaluated at both the Messenger Rna (mrna) and protein levels, resulted significantly higher Apoptosis\xa0in the Ovaries of the starved fetuses in comparison to control (fig.']	N/A	N/A	[('PR_000002193', 'apoptosis regulator BAX', 22, 'Bax'), ('PR_000002304', 'apoptosis regulator BAX isoform 6', 26, 'Bcl-2'), ('SO_0000233', 'mature_transcript', 61, 'messenger RNA'), ('GO_0006915', 'apoptotic process', 132, 'apoptosis'), ('UBERON_0000992', 'ovary', 149, 'ovaries')]
PMC5906686	4/2018	S182-PMC5906686	['the tunel assay was performed on paraffin Ovary sections as before43, using the brightgreen Apoptosis detection kit (vazyme, a112-02, nanjing, china) according to the manufactures’ instructions.']	N/A	N/A	[('UBERON_0000992', 'ovary', 42, 'ovary'), ('GO_0006915', 'apoptotic process', 92, 'Apoptosis')]
PMC5995352	6/2018	S20-PMC5995352	['rickets exerts a broad palette of symptoms including disturbed Apoptosis of the Chondrocytes leading to cartilage hyperplasia of the Growth Plates in the Metaphyseal Bone with widening of the Growth zones at Wrists, Ankles and Knees [2].']	N/A	N/A	[('GO_0006915', 'apoptotic process', 63, 'apoptosis'), ('CL_0000138', 'chondrocyte', 80, 'chondrocytes'), ('UBERON_0002516', 'epiphyseal plate', 133, 'growth plates'), ('UBERON_0001438', 'metaphysis', 154, 'metaphyseal bone'), ('UBERON_0002630', 'body of caudate nucleus', 192, 'growth'), ('UBERON_0004452', 'carpal region', 208, 'wrists'), ('UBERON_0004454', 'tarsal region', 216, 'ankles'), ('UBERON_0001465', 'knee', 227, 'knees')]
